Test Bank for Pharmacy Technician Principles and Practice, 3rd Edition: Hopper

Original price was: $35.00.Current price is: $26.50.

Test Bank for Pharmacy Technician Principles and Practice, 3rd Edition: Hopper Digital Instant Download

Category:

Test Bank for Pharmacy Technician Principles and Practice, 3rd Edition: Hopper

Product details:

  • ISBN-10 ‏ : ‎ 1437706711
  • ISBN-13 ‏ : ‎ 978-1437706710
  • Author: Hopper

With chapter-by-chapter review and practice, this easy-to-use workbook and lab manual helps you reinforce your understanding of key facts and concepts from Mosby’s Pharmacy Technician: Principles and Practice, 3rd Edition. A wide variety of review questions, exercises, and activities help you study more effectively and learn to apply your knowledge for success on the job.

Table contents:

  1. Who Will Benefit From This Book?
  2. Why is This Book Important to the Profession?
  3. Organization
  4. Distinctive Features of this Edition
  5. Drug Names and Pronunciations
  6. Tech Notes
  7. Tech Alerts
  8. Mini Drug Monographs
  9. Pharmacist’s Perspective
  10. Technician’s Corner
  11. New to This Edition
  12. New Chapter! Chapter 14: Medication Safety and Error Prevention
  13. Medical Terminology
  14. Appendix A: Review for the PTCB, EXPCT, or PEBC Examination
  15. Updated Pill Images
  16. Additional Math Exercises
  17. Overall Content Update
  18. Learning Aids
  19. Four-Color Design
  20. Extensive Visual Aids
  21. Chapter Objectives
  22. Key Terms
  23. Do You Remember These Key Points?
  24. Ancillaries
  25. For the Instructor
  26. TEACH Instructor Resource
  27. Instructor’s Resource.
  28. TEACH Online Pharmacy Technician Program Guide.
  29. Additional Instructor Ancillaries
  30. For the Student
  31. Ancillaries Available on the Evolve Companion Web Site
  32. Student Workbook/Lab Manual
  33. Acknowledgments
  34. Reviewers
  35. Contributors
  36. Dedication
  37. Section One General Pharmacy
  38. CHAPTER 1 History of Medicine and Pharmacy
  39. Objectives
  40. Terms and Definitions
  41. IMPORTANT PEOPLE
  42. History of Medicine
  43. Ancient Beliefs and Treatments
  44. The Medical Staff
  45. FIGURE 1-1 Medical staff.
  46. Medicine in Its Infancy
  47.  Tech Note!
  48. BOX 1-1
  49. The Hippocratic Oath
  50. Ancient Herbal Remedies
  51. TABLE 1-1 Advancements in Medicine
  52. Eighteenth- and Nineteenth-Century Medicine
  53. North American Medicine
  54. BOX 1-2
  55. Example of Prescription Compound from The 1900s
  56.  Tech Note!
  57. Opium and Alcohol
  58. BOX 1-3
  59. Typical Remedies of the 1800s in America
  60. BOX 1-4
  61. The Civil War
  62.  Tech Note!
  63. Origin of Opium (Opiates)
  64. Twentieth Century Medicine
  65. Advancements in Drug Therapy and Vaccinations
  66. BOX 1-5
  67. Laudanum Recipe from The 1700s
  68. TABLE 1-2 Examples of Important Vaccine Advancements in Medicine*
  69. Old Remedies Making a Comeback?
  70. History of Pharmacy
  71. Early Pharmacists
  72. Early Pharmacy in America
  73. FIGURE 1-2 Medications were compounded by hand using a variety of compounds.
  74. FIGURE 1-3 Large show globes (seen on top of shelf). An assortment of different mortars and pestles (seen on countertop).
  75. Early Pharmacy Technicians
  76. BOX 1-6
  77. Famous Pharmacists
  78. TABLE 1-3 Advancements in the Field of Pharmacy Technology
  79. Changing Pharmacy
  80. FIGURE 1-4 Pharmacy technician working in the pharmacy setting.
  81. Trust in Pharmacists/Trust in Technicians
  82. Technicians of the Twenty-First Century and Beyond
  83. Do You Remember These Key Points?
  84. Review Questions
  85. Multiple choice questions
  86. True/False
  87. Technician’s Corner
  88. Bibliography
  89. Websites Referenced
  90. For More Information on Topics Covered
  91. CHAPTER 2 Pharmacy Federal Laws and Regulations
  92. Objectives
  93. Terms and Definitions
  94. Introduction
  95. FDA History
  96. Early Activity of the FDA
  97. Description of Laws
  98. 1906 Federal Food and Drugs Act
  99. 1914 Harrison Narcotics Act
  100. 1938 Food, Drug, and Cosmetic Act
  101. 1951 Durham-Humphrey Amendment
  102. BOX 2-1
  103. Well-Known Federal Laws
  104. 1962 Kefauver-Harris Amendments
  105. 1970 Comprehensive Drug Abuse Prevention and Control Act
  106. 1970 The Poison Prevention Packaging Act (PPPA)
  107. 1983 Orphan Drug Act
  108. BOX 2-2
  109. PPPA Guidelines (Exempt Drugs)*
  110. 1987 Prescription Drug Marketing Act
  111. 1990 Omnibus Budget Reconciliation Act (OBRA ’90)
  112. 1996 Health Insurance Portability and Accountability Act (HIPAA)
  113. Patient Confidentiality
  114. What Information Is Protected?
  115. What Does This Mean for the Pharmacy?
  116. How Is Information Protected via the Computer?
  117. What Are the Rights of the Patient?
  118. Examples of What You (the Technician) Cannot Do
  119. BOX 2-3
  120. Examples of Breaching Confidentiality
  121. Examples of What Is Not Covered under HIPAA Patient Rights
  122. Public Health Activities
  123. Law Enforcement Purposes
  124. Examples
  125. 2000 Drug Addiction Treatment Act (DATA 2000)
  126. 2003 Medicare Modernization Act (MMA)
  127. 2005 Combat Methamphetamine Epidemic Act
  128. FIGURE 2-1 DEA poster on the misuse of pseudoephedrine.
  129. BOX 2-4
  130. Combat Methamphetamine Epidemic Act 2005
  131. TABLE 2-1 Additional Pharmacy-Related Acts
  132. Food and Drug Administration/Drug Enforcement Administration
  133. 1972 Drug Listing Act; National Drug Code (NDC)
  134. FIGURE 2-2 Example of NDC label.
  135. FDA Reporting Process and Adverse Reactions
  136. Recalled Drugs
  137. BOX 2-5
  138. NDC Number Specifics
  139. NDC 50580-449-05
  140. FIGURE 2-3 FDA MedWatch form.
  141. Controlled Substances
  142. BOX 2-6
  143. Sample Recall Notification
  144. Recall—Firm Press Release
  145. FIGURE 2-4 Codeine label showing C-II imprint.
  146. TABLE 2-2 Typical Controlled Substances
  147. Ratings of Scheduled (Controlled) Substances
  148. Tamper-Proof Prescriptions
  149. BOX 2-7
  150. Tamper-Proof Features
  151. FIGURE 2-5 Sample of tamper-proof prescription.
  152. Registration Required for Maintaining Narcotics
  153. Refilling Controlled Substances
  154. Ordering Controlled Substances
  155. FIGURE 2-6 Drug Enforcement Administration Form 222.
  156. TABLE 2-3 Examples of State Regulations for C-II Refills and C-III to C-V Refills
  157.  Tech Note!
  158. Record Keeping
  159. FIGURE 2-7 A, Pharmacy log sheet. B, Nursing floor log sheet.
  160. TABLE 2-4 Three Methods of Filing Controlled Substances and Legend Drugs
  161. Narcotic Inventory
  162. Reverse Distributor
  163.  Tech Note!
  164. Filling, Refilling, and Transferring Prescriptions for Controlled Drugs
  165. Original Filling of C-II through C-V
  166. Emergency Filling of C-II
  167. Refilling of C-II through C-V
  168. Partial Filling of C-II through C-V
  169. Transferring Controlled Drug Prescriptions C-II through C-V
  170. Dispensing Without a Prescription
  171. Lending or Transferring Schedule C-II through C-V Drugs to Another Pharmacy
  172. Mailing Controlled Substances C-II through C-V
  173. Monographs
  174. 1 Indications and Usage
  175. 2 Dosage and Administration
  176. 3 Dosage Forms and Strengths
  177. 4 Contraindications
  178. 5 Warnings and Precautions
  179. 6 Adverse Reactions
  180. 7 Drug Interactions
  181. 8 Use in Specific Populations
  182. 9 Drug Abuse and Dependence
  183. 10 Overdosage
  184. 11 Description
  185. 12 Clinical Pharmacology
  186. 13 Nonclinical Toxicology
  187. 14 Clinical Studies
  188. 15 References
  189. 16 How Supplied/Storage and Handling
  190. 17 Patient Counseling Information
  191. Boxed Warning
  192. FIGURE 2-8 Highlights of a drug monograph.
  193. Medguides
  194. Pregnancy Categories
  195. BOX 2-8
  196. (A) Special Warnings and Information
  197. (B) Example of Drugs Requiring Boxed Warning
  198. Prescription Regulation
  199. Who Can Prescribe?
  200. Who Can Receive a Prescription?
  201. BOX 2-9
  202. Pregnancy Categories
  203. Category A
  204. Category B
  205. Category C
  206. Category D
  207. Category X
  208.  Tech Note!
  209. Prescription Labels
  210. BOX 2-10
  211. Prescribing Authority
  212. Special Labeling
  213. Records and Labeling Requirements
  214. FIGURE 2-9 A, Sample of information necessary on a physician’s prescription order. B, Sample of information on a medication label.
  215. TABLE 2-5 Required Prescription Information*
  216. Repackaging
  217. Drug Enforcement Administration Verification
  218. BOX 2-11
  219. Drugs Requiring Additional Information
  220.  Tech Alert!
  221. Non–Child-Resistant Caps
  222. BOX 2-12
  223. Drug Enforcement Administration Verification Process of Prescriber’s DEA Number
  224. TABLE 2-6 Prescription Drugs That Can Be Packaged in Non–Child-Resistant Bottles
  225. Special Prescribing Programs
  226. Programs for Opioid Maintenance
  227. Methadone Maintenance Treatment (MMT)
  228. Suboxone and Subutex
  229. Risk Management Programs for Prescription Drugs
  230. iPledge Program under the FDA
  231.  Tech Alert!
  232. Pharmacy Sites
  233. Brick and Mortar and Mail-Order Pharmacies
  234. Online Pharmacies (E-Pharmacy)
  235. Occupational Safety and Health Administration
  236. BOX 2-13
  237. Common Safety and Health Topics
  238. Material Safety Data Sheets (MSDS)
  239. The Joint Commission
  240. Legal Standards
  241. State Laws
  242. Liabilities
  243.  Tech Alert!
  244. Pharmacy Employee Requirements: Request for Waiver
  245. Do You Remember These Key Points?
  246. Review Questions
  247. Multiple choice questions
  248. True/False
  249. Technician’s Corner
  250. Bibliography
  251. Referenced Websites
  252. CHAPTER 3 Pharmacy Ethics, Competencies, Associations, and Settings for Technicians
  253. Objectives
  254. Terms and Definitions
  255. Introduction
  256. Historical Data
  257. Competencies
  258. Current Qualifications
  259. BOX 3-1
  260. White Paper on Pharmacy Technicians 2002
  261. Nondiscretionary Duties
  262. BOX 3-2
  263. Chapter References Citing Common Responsibilities and Competencies of A Pharmacy Technician
  264. Basic Nondiscretionary Skills
  265. Typing
  266. Computers
  267. Reports and Documentation
  268. Ordering Supplies
  269. BOX 3-3
  270. Examples of Federal Laws Governing Pharmacy
  271. Prescription Records
  272. Patient Consultation (OBRA ’90)
  273.  Tech Note!
  274. Inpatient Setting Requirements
  275.  Tech Note!
  276. FIGURE 3-1 Room for preparing intravenous solutions for inpatients.
  277. Community (Outpatient) Setting Requirements
  278. FIGURE 3-2 Outpatient filling station.
  279. Closed Door Pharmacy Requirements
  280. FIGURE 3-3 Home health and long-term pharmacy industry setting.
  281. Mail-Order Pharmacy and E-Pharmacy
  282. Ethics and Communication in the Workplace
  283. Professionalism
  284. Morals Versus Ethics in the Workplace
  285. Protocol
  286. Communication
  287. BOX 3-4
  288. Pharmacy Technician Code of Ethics
  289. Preamble
  290. Principles
  291. Listening Skills
  292. FIGURE 3-4 Technician helping customer.
  293. Body Language
  294. Verbal Communications
  295. Vocal: How You Sound
  296. BOX 3-5
  297. Example of Negative Body Language
  298. How to Improve Your Vocal Communication Skills
  299. Verbal: What You Say
  300. First Way of Handling a Problem
  301. Second Way of Handling the Same Problem
  302. How to Improve Your Verbal Skills
  303. Phone Etiquette
  304. Written Communication
  305. Confidentiality
  306. Terminally Ill Patients
  307. BOX 3-6
  308. Example of Unacceptable Phone Etiquette
  309. BOX 3-7
  310. Example of Poor Written Communication Skills
  311. Information That Should Be Obtained and Written Down in the Message:
  312. BOX 3-8
  313. Example of Breach of Confidentiality
  314. Training Programs for the Pharmacy Technician Student
  315. Different Levels of Pharmacy Technicians
  316. BOX 3-9
  317. ASHP Course Curriculum Requirements
  318. National Certification for Technicians
  319. BOX 3-10
  320. Goals of PTCB and Exam Requirements
  321. Goals
  322. Eligibility Requirements to Take the Exam Include the Following:
  323. Continuing Education
  324. TABLE 3-1 Comparisons of National Certification Examinations
  325.  Tech Note!
  326.  Tech Alert!
  327. Opportunities for Technicians
  328. TABLE 3-2 Examples of Continuing Education Website Portals for Technicians
  329. BOX 3-11
  330. PTCB Qualifications and Common Duties of Certified Technicians
  331. Job Duties
  332. Knowledge, Skills, Training, and Education
  333. Incentive Programs
  334. The Professional Technician Associations
  335. American Pharmacists Association (Apha)
  336. American Society of Health-System Pharmacists (AShP)
  337. TABLE 3-3 Organizations/Associations for Pharmacy Technicians*
  338. American Association of Pharmacy Technicians (AAPT)
  339. National Community Pharmacists Association (NCPA)
  340. National Pharmacy Technician Association (NPTA)
  341. BOX 3-12
  342. Internet Sites for Jobs
  343. The Job Search
  344. The Resume
  345. Professional Dress
  346.  Tech Note!
  347. The Possibilities
  348. BOX 3-13
  349. Resume Help
  350. Do You Remember These Key Points?
  351. Review Questions
  352. Multiple choice questions
  353. True/False
  354. Technician’s Corner
  355. Bibliography
  356. CHAPTER 4 Conversions and Calculations Used by Pharmacy Technicians
  357. Objectives
  358. Terms and Definitions
  359. Introduction
  360.  Tech Note!
  361. History of Pharmacy
  362. Roman Numerals
  363. Rules for Determining Roman Numerals
  364. EXAMPLE 4-1  Working with Roman Numerals
  365. TABLE 4-1 Arabic and Roman Numerals
  366. EXERCISE 4-1 Quick Check
  367. International Time (Military Time)
  368. FIGURE 4-1 Military clock versus traditional clock.
  369. EXERCISE 4-2 Quick Check
  370. Practice Quiz #1 (Roman Numerals and Time)
  371. BOX 4-1
  372. Time Conversions
  373. Fill in the blanks:
  374. Multiplication/Division
  375. EXERCISE 4-3 Quick Check
  376. TABLE 4-2 Multiplication Chart
  377. Fractions, Decimals, Percentages, Ratios, and Proportions
  378. Converting Fractions to Decimals
  379. EXERCISE 4-4 Quick Check
  380. Converting Fractions to Percentages
  381. Converting Ratios to Percentages
  382. Converting Decimals to Percentages
  383. EXERCISE 4-5 Quick Check
  384. Ratios/Proportions
  385. EXAMPLE 4-2
  386. EXAMPLE 4-3
  387.  Tech Note!
  388. EXERCISE 4-6 Quick Check
  389. Other Examples of Proportion Problems
  390. EXAMPLE 4-4
  391. EXAMPLE 4-5
  392. EXAMPLE 4-6
  393. Answer to question 1
  394. Answer to question 2
  395. Answer to question 3
  396. Answer to question 4
  397. EXAMPLE 4-7
  398.  Tech Note!
  399. Example of Proportions in Compounding
  400. Working with Word Problems
  401. EXAMPLE 4-8
  402. EXAMPLE 4-9
  403. EXERCISE 4-7 Quick Check
  404. Determine 1 Dose
  405. TABLE 4-3 Metric Prefixes
  406. Practice Quiz #2 (Decimals, Fractions, Percentages)
  407. Convert the following percents to decimals
  408. Convert the following fractions to percents
  409. Metric System
  410. Metric Measurements
  411.  Tech Alert!
  412. EXERCISE 4-8 Quick Check
  413. TABLE 4-4 Metric-Household Conversion Measurements
  414. Household Measurements
  415. EXAMPLE 4-10
  416. EXAMPLE 4-11
  417. EXAMPLE 4-12
  418.  Tech Note!
  419. EXERCISE 4-9 Quick Check
  420. Apothecary System
  421. FIGURE 4-2 Oral cups show equivalent volumes between household to metric and household to apothecary units.
  422. EXAMPLE 4-13
  423. Using 65 mg/grain
  424. EXAMPLE 4-14
  425. Using 65 mg/grain
  426. EXERCISE 4-10 Quick Check
  427.  Tech Note!
  428. TABLE 4-5 Standard Weights and Volumes: Avoirdupois/Metric*
  429. EXERCISE 4-11 Quick Check
  430. Avoirdupois System
  431. Avoirdupois Measurements
  432. EXERCISE 4-12 Quick Check
  433. Volumes
  434. Weights
  435. Practice Quiz #3
  436. Important Differences among Systems
  437. TABLE 4-6 Apothecary/Metric/Household Conversions
  438. BOX 4-2
  439. Time Schedule (Pharmacy Abbreviations)
  440. FIGURE 4-3 Common devices used for measuring liquid medications.
  441. Oral Syringes and Injections
  442. Pediatric and Geriatric Dosing
  443. EXAMPLE 4-15
  444. EXAMPLE 4-16
  445. Calculating the Proper Dose
  446. EXERCISE 4-13 Quick Check
  447.  Tech Note!
  448. Calculating Pediatric Dosage
  449. EXAMPLE 4-17
  450. EXERCISE 4-14 Quick Check
  451.  Tech Note!
  452. Calculating Body Surface Area (BSA)
  453. Other Methods of Calculating Pediatric Doses
  454. Geriatric Patients
  455. EXERCISE 4-15 Quick Check
  456.  Tech Note!
  457. Drip Rates
  458.  Tech Note!
  459. EXAMPLE 4-18  Calculating Drip Rates
  460. EXERCISE 4-16 Quick Check
  461. EXAMPLE 4-19  Determining Volume Based on Drop Factor (DF)
  462. EXAMPLE 4-20
  463.  Tech Note!
  464. Dilution
  465. FIGURE 4-4 Large-volume IV drip with smaller piggyback attached to tubing on pump.
  466. EXERCISE 4-17 Quick Check
  467. Alligation
  468.  Tech Note!
  469. EXERCISE 4-18 Quick Check
  470. Practice Quiz #4
  471. Do You Remember These Key Points?
  472. Test Questions
  473. Convert the following units into percentages
  474. Convert the following fractions of grains into milligrams
  475. Write the Arabic numbers in Roman numerals and the Roman numerals in Arabic numbers
  476. Convert the following metric units into the units indicated to the right
  477. Solve the following drug orders. Be sure to show your work. Use the following conversions
  478. Technician’s Corner
  479. Bibliography
  480. CHAPTER 5 Dosage Forms, Routes of Administration and Drug Classifications, Drug Abbreviations, and Medical Terminology
  481. Objectives
  482. Terms and Definitions
  483. TERMS AND ABBREVIATIONS
  484. Introduction
  485. Where Did Pharmacy Abbreviations Originate?
  486. Do Not Use List
  487. Dosing Instructions
  488. TABLE 5-1 TJC Official “Do Not Use” List*
  489. TABLE 5-2 ISMP Error-Prone Abbreviations, Symbols, and Dosage Designations
  490. Classifications of Medications
  491. TABLE 5-3 General Classifications of Medications
  492. Different Types of Drug Sales
  493. Dosage Forms
  494. FIGURE 5-1 A, Unscored tablet. B, Scored tablet.
  495. FIGURE 5-2 A, Plain tablets. B, Scored tablets. C, Enteric-coated tablets.
  496. TABLE 5-4 25 Top Selling Generic Drugs with Multiple Dosage Forms
  497.  Tech Note!
  498. Solids
  499. Tablets/Caplets
  500.  Tech Note!
  501. Capsules
  502. Capsule Sizes
  503. FIGURE 5-3 Different types of capsules.
  504. FIGURE 5-4 Types of capsules. A, Capsules. B, Extended-release capsules.
  505. FIGURE 5-5 Different sizes of capsules. Eight sizes are available; each holds a specific volume, and each holds a specific amount of medication. The size numbers are 5, 4, 3, 2, 1, 0, 00, 000—5 being the smallest and 000 being the largest.
  506. Example of Caplets and Capsules
  507. Lozenges/Troches
  508. Example of Lozenges and Troches
  509. Biomaterials
  510. Implants
  511. Transdermal Patches
  512. FIGURE 5-6 A, Example of nitroglycerin ointment patch. B, Example of a transdermal patch.
  513. Example of Topical patches
  514.  Tech Alert!
  515. Liquids
  516. Syrups
  517. Example of Syrups
  518. Elixirs
  519. Example of Elixirs
  520. Sprays
  521. Example of Sprays
  522. Inhalants and Aerosols
  523. Example of Aerosol and Mdis
  524.  Tech Note!
  525. Emulsions
  526. FIGURE 5-7 A, Inhaler. B, Inhaler attached to an AeroChamber (also known as a spacer).
  527. Example of Emulsions
  528.  Tech Note!
  529. Suspensions
  530. Example of Suspensions
  531.  Tech Note!
  532. Enemas
  533. Example of Enemas
  534. Semisolids
  535. Creams
  536. Example of creams
  537. Lotions
  538. Example of Lotions
  539. Ointments
  540. Example of Ointments
  541. Gels
  542. Example of Gels
  543. Pastes
  544. Example of Pastes
  545. Suppositories
  546. Example of Suppositories
  547. Powders
  548. Example of Powders
  549. Injectables
  550. Example of Injectables
  551. FIGURE 5-8 A, Medication in vials. B, Medication in ampules.
  552. FIGURE 5-9 This type of vial is called Add-A-Vial or Mix-O-Vial. The advantage of this type of medication dosage form is its longer shelf life. 1, First remove the sterile cap. 2, The powder is below, and the sterile diluent is on top of the vial. The vial is divided by a rubber stopper in the middle. 3, Push the plunger down, forcing the stopper to fall into the bottom of the vial. This allows the diluent to mix with the powder. Shake well. Once dissolved, the medication is ready to be used.
  553. FIGURE 5-10 On the left is a large-volume IV. On the right is an IV piggyback.
  554. Routes of Administration
  555. By Mouth, or Oral
  556. Sublingual and Buccal Agents
  557. TABLE 5-5 Common Abbreviations Used with Dosage Forms
  558. FIGURE 5-11 A, Sublingual tablet placement. B, Buccal tablet placement.
  559. Rapidly Disintegrating Oral Tablets
  560. Rectal Agents
  561. Topical Agents
  562. Parenteral: Intravenous, Intravenous Piggyback, Intramuscular, and Subcutaneous Agents
  563. Eye/Ear/Nose (ophthalmic, otic, nasal)
  564. Inhalants
  565. Injectable (Long-Acting)
  566. Miscellaneous Routes
  567. Other Considerations: Form and Function
  568. Pharmacokinetics vs. Pharmacodynamics
  569. Absorption
  570. Distribution
  571. FIGURE 5-12 Lock-and-key mechanism allowing absorption to take place in a cell. These common reactions take place naturally throughout the body. Only after the correct receptor makes a connection with the matching receptor site will the cell allow a reaction to take place. Medications often mimic this natural mechanism.
  572. BOX 5-1
  573. Ionization
  574. Metabolism
  575. Excretion/Elimination
  576. Bioavailability
  577. Half-Life
  578. Bioequivalence
  579. The Use of Excipients
  580. Manufactured Products
  581. TABLE 5-6 Description of Additives
  582. TABLE 5-7 Description of Dosage Forms
  583. TABLE 5-8 Examples of Storage Requirements
  584. Packaging and Storage Requirements
  585. Medical Terminology
  586. TABLE 5-9 Abbreviations for Conditions or Body Systems
  587. BOX 5-2
  588. Overview of Word Parts of Medical Terminology
  589. Rules
  590. TABLE 5-10 Common Body System Word Segments
  591. Do You Remember These Key Points?
  592. Review Questions
  593. Multiple choice questions
  594. True/False
  595. Technician’s Corner
  596. Question
  597. Bibliography
  598. Websites
  599. CHAPTER 6 Drug Information References
  600. Objectives
  601. Terms and Definitions
  602. Introduction
  603. Understanding the Correct Way to Reference
  604.  Tech Note!
  605. BOX 6-1
  606. Examples of Trade Drug Names That Indicate the Function of the Drug
  607.  Tech Note!
  608. References Used in Pharmacy
  609. Drug Facts and Comparisons
  610. BOX 6-2
  611. Examples of Similar Endings of Generic Drug Names
  612. Physicians’ Desk Reference
  613. TABLE 6-1 Sections in Drug Facts and Comparisons
  614. TABLE 6-2 Sections of Physicians’ Desk Reference
  615. Drug Topics Red Book
  616. BOX 6-3
  617. Example of Information in Drug Facts and Comparisons
  618. Omeprazole
  619. Looking Up Information Under Trade Name:
  620. Looking Up Information Under Generic Name:
  621. TABLE 6-3 Sections in Drug Topics Red Book
  622. Approved Drug Products with Therapeutic Equivalence Evaluations: “Orange Book”
  623. American Hospital Formulary Service Drug Information
  624. United States Pharmacopeia–National Formulary (USP–NF)
  625. TABLE 6-4 Abbreviations in Drug Topics Red Book
  626. United States Pharmacists’ Pharmacopeia
  627. Clinical Pharmacology and Other Gold Standard/Elsevier Products
  628. Ident-A-Drug
  629. FIGURE 6-1 Screen shot from Clinical Pharmacology showing a drug monograph.
  630. Micromedex Healthcare Series
  631. FIGURE 6-2 Screen shot from Clinical Pharmacology showing a pill using the Drug IDentifier.
  632. Trissel’s Handbook on Injectable Drugs
  633. American Drug Index
  634. Goodman & Gilman’s the Pharmacological Basis of Therapeutics
  635. Handbook of Nonprescription Drugs by Apha
  636. Martindale’s The Complete Drug Reference
  637. Remington’s Pharmaceutical Sciences: The Science and Practice of Pharmacy
  638. Pediatric Dosage Handbook (Lexi-Comp)
  639. Geriatric Dosage Handbook (Lexi-Comp)
  640. TABLE 6-5 Main Attributes of Various References
  641. Pocket-Sized Reference Books
  642. Electronic Referencing
  643. The Internet
  644. Journals and Newsmagazines
  645. TABLE 6-6 Online Websites and Databases
  646. Additional Types of Information
  647. TABLE 6-7 Types of Journals and Pharmacy Magazines Available
  648. TABLE 6-8 Additional Reference Books That Technicians May Find Helpful in Understanding Various Aspects of Health Care
  649.  Tech Note!
  650. Considerations When Choosing a Reference
  651. BOX 6-4
  652. Pharmacy Associations* that Provide Continuing Education and Information
  653.  Tech Note!
  654. Do you Remember These Key Points?
  655. Review Questions
  656. Multiple choice questions
  657. True/False
  658. Technician’s Corner
  659. Bibliography
  660. Websites
  661. CHAPTER 7 Prescription Processing
  662. Objectives
  663. Terms and Definitions
  664. Introduction
  665. Processing a Prescription: A Step-by-Step Approach
  666. Receiving the Prescription
  667.  Tech Note!
  668. Prescription Information
  669. Community Pharmacy Setting
  670. Institutional Setting
  671.  Tech Note!
  672. FIGURE 7-1 Example of physician’s prescription.
  673. BOX 7-1
  674. Commonly Followed Rules for Taking Prescriptions
  675. Call-in
  676. Fax
  677. Walk-in
  678. E-Prescribing
  679. The following are some benefits of using E-prescribing:
  680. The following are some barriers for E-prescribing:
  681.  Tech Note!
  682. Translation of an Order
  683. BOX 7-2
  684. Required Patient Information in a Community Setting
  685. Patient Information:
  686. Provider’s Information:
  687. Prescription Information:
  688. When to Ask for Help
  689.  Tech Note!
  690.  Tech Note!
  691. Entering the Information into the Database
  692. Community Setting
  693. BOX 7-3
  694. Required Patient Information in an Institutional Setting
  695. Patient Information:
  696. Prescriber Information:
  697. Prescription Order Information:
  698. Other Important Information, Usually Available from Medical Chart or Nursing Staff:
  699. Institutional Setting
  700. FIGURE 7-2 Technicians may enter information into the computer system in many pharmacy settings.
  701. Filling the Prescription in a Community Setting
  702.  Tech Note!
  703. 1 Verifying the Prescription
  704. FIGURE 7-3 Technicians filling prescriptions.
  705.  Tech Note!
  706. 2 Pulling the Correct Medication
  707.  Tech Note!
  708. 3 and 4 Counting and Filling the Medication
  709. FIGURE 7-4 Pulling medication from the shelf.
  710. 5 Prescription Lids
  711. 6 Applying the Label
  712. FIGURE 7-5 Technician counting and pouring tablets into medication vial.
  713. TABLE 7-1 Exceptions for Safety Lids*
  714.  Tech Note!
  715. 7 Technician’s Initials
  716. 8 Auxiliary Labels
  717.  Tech Note!
  718. 9 and 10 Pharmacist’s Final Inspection
  719. FIGURE 7-6 Applying an auxiliary label.
  720. TABLE 7-2 Commonly Used Auxiliary Labels for Side Effects
  721. Community Dispensing Systems
  722. Filling Orders in an Institutional Setting
  723. BOX 7-4
  724. Advantages of a Computer Dispensing System
  725. Computer Dispensing Systems
  726. Inpatient Dispensing Systems
  727. The 5 Rights of Medication SafetY
  728. Pharmacist Consultations: When and Who Needs Them
  729. Miscellaneous Orders
  730. Community Setting
  731. Daily Hard-Copy Printing (QUEUE)
  732. FIGURE 7-7 Patient consultation.
  733. Refills
  734.  Tech Note!
  735. Zero Refill Reorders
  736. Transfers
  737. Refilling Automated Dispensing System (ADS) Machines
  738.  Tech Note!
  739. Filing Prescriptions
  740. TABLE 7-3 Filing Prescriptions
  741. Early Fills
  742. Medication Pickup
  743. Billing Patients
  744. Changing Trends
  745. Do You Remember These Key Points?
  746. Review Questions
  747. Multiple choice questions
  748. True/False
  749. Technician’s Corner
  750. Bibliography
  751. CHAPTER 8 Over-the-Counter Medications
  752. Objectives
  753. Terms and Definitions
  754. Introduction
  755. FIGURE 8-1 More than 100,000 OTC products exist from different combinations of only 1000 ingredients.
  756. Three FDA Categories Concerning Classification of Over-the-Counter Drugs
  757. TABLE 8-1 Common Over-the-Counter Brand Preparations
  758. Food and Drug Administration Regulations
  759. Purity
  760. BOX 8-1
  761. Types Of Product Additives
  762. Potency
  763. Bioavailability
  764. Efficacy
  765. Safety and Toxicity
  766. BOX 8-2
  767. Medications Measured in Units (Requires a Prescription)
  768. How a Prescription Drug Becomes an Over-the-Counter Drug
  769. BOX 8-3
  770. Food and Drug Administration Phases of Over-the-Counter Drug Approval
  771. TABLE 8-2 OTC Versus Rx Medications
  772. Conditions Treated with Over-the-Counter Drugs
  773. Analgesics and Antipyretics
  774. TABLE 8-3 Common Types of Over-the-Counter Products*
  775. Common Patient Information
  776.  Tech Note!
  777.  Tech Note!
  778. Interactions between Aspirin and Other Agents
  779. TABLE 8-4 Analgesics and Antipyretic Products
  780. TABLE 8-5 Examples of Common and Important Interactions between Aspirin and Other Medications
  781. Headache Products
  782. Antiinflammatories
  783. Common Patient Information
  784.  Tech Note!
  785. Allergy and Cold Agents
  786. Decongestants
  787. TABLE 8-6 Headache Products
  788. TABLE 8-7 Antiinflammatory Products
  789. Common Patient Information
  790. Antihistamines
  791. Common Patient Information
  792. Sleep Aids
  793. TABLE 8-8 Decongestant Products
  794. TABLE 8-9 Oral Antihistamine Products*
  795. Common Patient Information
  796. Cough Medicines
  797. Common Patient Information
  798. Sore Throat Products
  799. TABLE 8-10 Antiinsomnia Products
  800. TABLE 8-11 Cold and Cough Products
  801. TABLE 8-12 Sore Throat Products
  802. Common Patient Information
  803.  Tech Note!
  804. Stomach Remedies/Antacids
  805. Common Patient Information
  806.  Tech Note!
  807. Intestinal Remedies
  808. TABLE 8-13 Stomach Products/Antacids
  809. Common Patient Information
  810. Skin Remedies
  811. Geriatric and Pediatric Considerations
  812. TABLE 8-14 Intestinal Products
  813. TABLE 8-15 Over-The-Counter Skin Products
  814. TABLE 8-16 Common Agents Used to Treat a Variety of Conditions
  815. TABLE 8-17 Effects Drugs Have on an Aging Body
  816. Behind-the-Counter Drugs
  817. Do You Remember These Key Points?
  818. Review Questions
  819. TABLE 8-18 Current BTC Medications
  820. Multiple choice questions
  821. True/False
  822. Technician’s Corner
  823. Reference
  824. Bibliography
  825. Websites
  826. Websites
  827. CHAPTER 9 Complementary and Alternative Medicine
  828. Objectives
  829. Terms and Definitions
  830. Agents Covered In This Chapter
  831. Introduction
  832. What Is Alternative Medicine?
  833. Overview of Eastern versus Western Medicine
  834. Trends toward Alternatives
  835. Organizations Related to Alternative Medicine
  836. Maggot Therapy
  837. TABLE 9-1 Twelve Alternative Treatments
  838. TABLE 9-2 BTER Foundation Research Areas
  839. Leech Therapy
  840. Ancient Chinese Medicine
  841. BOX 9-1
  842. Ugly Medicine
  843. Leeches
  844. Maggots
  845. Acupuncture
  846. Acupressure
  847. FIGURE 9-1 Acupuncture.
  848. FIGURE 9-2 Acupressure points.
  849. Additional Forms of Complementary and Alternative Medicine
  850. Art Therapy
  851. Ayurveda
  852. Biofeedback
  853. Chiropractic Therapy
  854. FIGURE 9-3 Biofeedback. Example of electrode placement.
  855. Pharmacist’s Perspective
  856. Educate Yourself about Complementary and Alternative Medicine and Health
  857. Herbal Medicine
  858. TABLE 9-3 Examples of Herbal-Drug Interactions
  859. Herbal Treatments
  860. TABLE 9-4 Common Uses and Cautionary Notes for Herbals
  861. FIGURE 9-4 Black cohosh.
  862. FIGURE 9-5 Garlic.
  863. FIGURE 9-6 Purple coneflower.
  864. Herbal Preparations
  865. TABLE 9-5 Herbal Preparations
  866. Homeopathy
  867.  Tech Note!
  868. The Placebo Effect
  869. Do You Remember These Key Points?
  870. Review Questions
  871. Multiple choice questions
  872. True/False
  873. Technician’s Corner
  874. Bibliography
  875. Websites Referenced
  876. CHAPTER 10 Hospital Pharmacy
  877. Objectives
  878. Terms and Definitions
  879. Introduction
  880. Types of Hospitals
  881. Hospital Pharmacy Standards and Procedures
  882. Policies and Procedures
  883. TABLE 10-1 Example of Various Sizes and Types of Hospitals
  884.  Tech Note!
  885. Hospital Protocol
  886.  Tech Note!
  887. Hospital Standards
  888. Hospital Orders
  889. Flow of Orders
  890. FIGURE 10-1 The flow of orders. As orders arrive, they are entered into the computer. If an order is unclear or if there is a question, the pharmacist contacts the physician.
  891. FIGURE 10-2 Example of a physician’s order. Note the medical record number in place of a prescription number. Also, the patient’s room number and allergies should be listed (not shown).
  892. FIGURE 10-3 Pneumatic tube system. A pneumatic tube system is used to transport orders to the pharmacy and medications to hospital floors.
  893. Point of Entry (POE)
  894. Computerized Physician Order Entry (CPOE)
  895. Bar Code Point of Entry (BPOE)
  896. Computerized Adverse Drug Event Monitoring (CADM)
  897. Responsibilities of an Institutional Technician
  898. Patient Cassette Drawers
  899. TABLE 10-2 Common Job Descriptions
  900. Preparing Unit Dose Medications
  901. Unit Dose Liquids
  902. Controlled Substances
  903. Description
  904. Duties
  905. Daily IV Preparation Duties
  906. Aseptic Technique
  907. USP <797>
  908. IV Tech
  909. Description
  910. Chemotherapy Preparation
  911. Description
  912. FIGURE 10-4 Airegard 301 (Horizontal Laminar Flowhood Clean Bench).
  913. FIGURE 10-5 Vertical flow hood.
  914. FIGURE 10-6 Proper placement of labels on parenteral solutions.
  915.  Tech Alert!
  916. Labeling
  917. Description
  918.  Tech Alert!
  919. Inventory Control Technician
  920. Description
  921. Duties
  922. Supplying Specialty Areas
  923. BOX 10-1
  924. Examples of Primary Units and Areas that Require Medication from Pharmacy
  925.  Tech Alert!
  926. Nonclinical Areas Stocked by the Pharmacy
  927. BOX 10-2
  928. Examples of Hospital Codes*
  929. Central Supply
  930. TABLE 10-3 Commonly Used Crash Cart Medications and Their Classification
  931. BOX 10-3
  932. Special Departments Stocked by the Pharmacy
  933. Glove Boxes
  934. FIGURE 10-7 Labgard 437: Glove box for IV admixture.
  935. Automated Dispensing Systems (ADSs)
  936. Additional Areas of Pharmacy
  937. Satellite Pharmacies
  938. Description
  939. Duties
  940. Discharge Pharmacy
  941. Description
  942. Duties
  943. Pharmacy and Nursing Staff Relationship
  944. BOX 10-4
  945. Ads Manufacturers
  946.  Tech Note!
  947. Stat and ASAP Orders
  948. Specialty Tasks
  949. Investigational Drugs/Biological Therapies
  950. Do You Remember These Key Points?
  951. Review Questions
  952. Multiple choice questions
  953. True/False
  954. Technician’s Corner
  955. Bibliography
  956. Websites
  957. CHAPTER 11 Repackaging and Compounding
  958. Objectives
  959. Terms and Definitions
  960. Introduction
  961. Repackaging
  962.  Tech Note!
  963. Repackaging Equipment
  964. Repackaging Techniques
  965. TABLE 11-1 Examples of Good Manufacturing Practice Guidelines
  966. FIGURE 11-1 Sample of containers.
  967. FIGURE 11-2 A sample blister pack container.
  968. FIGURE 11-3 A technician is responsible for the proper preparation and labeling of all repackaged medications. A, The empty medication card is rotated under the hopper, where the medication is placed into the card. The medication card is then rotated to the heating element, where the seal is made to enclose each tablet. B, The technician uses a mirror to verify that each sheet is filled completely.
  969. TABLE 11-2 Unit Dose Containers
  970.  Tech Note!
  971. Documentation
  972. Labeling and Checking Repackaged Medications
  973. FIGURE 11-4 Sample of a unit dose log record.
  974. TABLE 11-3 Example of Unit Dose Record Log Sheet Information*
  975. TABLE 11-4 Examples of Manufacturer Abbreviation Codes
  976.  Tech Alert!
  977. Storage and Stability
  978. Expiration Dates Versus Beyond-Use Dating
  979. Method 1
  980. EXAMPLE 11-1 Expiration Dating (6-Month Version)
  981. Method 2
  982. EXAMPLE 11-2 Beyond-Use Dating (1-Year Version)
  983.  Tech Alert!
  984. Compounding
  985. History
  986. Non–Sterile Compounding
  987. BOX 11-1
  988. Why Compound Medications?
  989. Compounding Area
  990. Equipment
  991. Personal Protective Equipment
  992. BOX 11-2
  993. Examples of Dosage Forms that Can be Compounded
  994. Topicals
  995. Oral Liquids
  996. Oral Solids
  997. Suppositories
  998. Measuring Devices
  999. TABLE 11-5 Examples Of Compounding Equipment
  1000. Mixing Equipment
  1001. FIGURE 11-5 Graduated cylinders are used for liquid measurement.
  1002. TABLE 11-6 Types of Graduated Cylinders
  1003. FIGURE 11-6 Mortars and pestles are used to crush solids. Both glass and porcelain types are used in compounding.
  1004. TABLE 11-7 Types of Compounding Mixing Equipment
  1005. Weighing Equipment
  1006. FIGURE 11-7 A, Class A balance. B, Pharmaceutical weights. C, Analytical balance.
  1007. Additional Supplies
  1008. Mold Forms
  1009. Excipients
  1010. Taste
  1011. TABLE 11-8 Common Additives
  1012. TABLE 11-9 Common Flavor Additives for Taste*
  1013. Non–Sterile Compounding and Techniques
  1014. Personal Preparation
  1015. Weighing Techniques
  1016. BOX 11-3
  1017. Competencies
  1018.  Tech Note!
  1019. Measuring Liquids
  1020. Preparing Solutions
  1021. BOX 11-4
  1022. Instructions for Using a Class a Balance
  1023. Solubility
  1024.  Tech Note!
  1025. Reconstituting Premade Suspensions
  1026. FIGURE 11-8 The meniscus is the level at which liquids are measured and recorded. For accuracy always have the container at eye level when determining the volume.
  1027. Solids: Tablets, Capsules, and Lozenges
  1028. BOX 11-5
  1029. Solubility Characteristics
  1030. TABLE 11-10 Common Auxiliary Labels Placed on Medication Containers
  1031. Molded Tablets
  1032. Tablet Molds
  1033. Steps Necessary for Preparation of Molded Tablets
  1034. Compressed Tablets and Lozenges
  1035. BOX 11-6
  1036. Tablet Additives
  1037. Making a Tablet
  1038. Compounding Capsules
  1039. BOX 11-7
  1040. Calibrating the Mold
  1041. BOX 11-8
  1042. Compounding Procedure for Molded Tablets
  1043. Lozenges
  1044. TABLE 11-11 Capsule Sizes
  1045. Hard Lozenges
  1046. Soft Lozenges
  1047. Chewable Lozenges
  1048. Semisolids: Ointments, Sticks, and Suppositories
  1049. Medication Sticks
  1050. Filling Ointment Jars
  1051. Filling Ointment Tubes
  1052. Soft Sticks
  1053. BOX 11-9
  1054. Classifications of Ointment Bases
  1055. Formulations
  1056. Suppositories
  1057. Oleaginous Bases
  1058. Water-Soluble Bases
  1059. Glycerinated Gelatins
  1060. Preparing Suppositories
  1061. Using Molds
  1062. FIGURE 11-9 Suppository molds can be used as well as hand-rolled method. A, Suppository molds prepared in the pharmacy. B, Suppository packaging.
  1063. Using Hand-Rolling Method
  1064. Packaging Suppositories
  1065. Nasal Preparations: Ointments, Suspensions, Gels, and Solutions
  1066. Preparing Solution
  1067. Preparing Suspensions
  1068. Preparing Ointments
  1069. Preparing Gels
  1070.  Tech Alert!
  1071. Packaging
  1072. TABLE 11-12 Types of Containers/Sealants and Dosage Forms They Contain
  1073.  Tech Note!
  1074. Stability
  1075. Documentation
  1076. Safety
  1077. TABLE 11-13 USP <795> Guidelines
  1078. Sterile Compounding
  1079. BOX 11-10
  1080. Information Necessary on Compounding Log Sheet and Medication Label
  1081. Log Sheet Information
  1082. Medication Label Information
  1083. Ophthalmic Agents
  1084.  Tech Note!
  1085. EXAMPLE 11-3
  1086. Cefazolin Super Eye Drops
  1087.  Tech Alert!
  1088. Compounding Professionalism
  1089. Regulatory and Quality Control
  1090. Chemotherapeutic Agents
  1091. Veterinary Medications
  1092. BOX 11-11
  1093. Labeling Requirements for Animal Prescriptions
  1094. TABLE 11-14 Pet Dosage Forms and Flavorings
  1095. Compounding
  1096. Personnel Training
  1097. Compounding Calculations
  1098. Reducing or Enlarging Formulas
  1099. Determining Partial Dosage Units
  1100. Changing Stock Solutions
  1101. Mixing Products of Different Strengths
  1102. Performing Solubility Expressions
  1103. Converting Units to Weights
  1104. Do you Remember These Key Points?
  1105. Review Questions
  1106. Multiple choice questions
  1107. True/False
  1108. Technician’s Corner
  1109. Bibliography
  1110. Websites Referenced
  1111. CHAPTER 12 Aseptic Technique
  1112. Objectives
  1113. Terms and Definitions
  1114. Introduction
  1115. Terminology Used in Pharmacy
  1116. Standard Precautions of a Health Care Worker
  1117. BOX 12-1
  1118. Abbreviations and Descriptions of Pharmacy Stock
  1119. Types of Containers Used for Preparing Parenteral Medications; Description of Container and/or Contents
  1120. Common Types of Solutions Used/Ordered for Parenteral Agents
  1121. Routes of Administration for Parenteral Agents
  1122. Miscellaneous Terms Used Concerning Parenteral Medications
  1123. Supplies
  1124. Syringes
  1125. FIGURE 12-1 Anatomy of a syringe. As the syringe decreases in size, the calibrations (volume markers) become larger, allowing a more accurate dosage.
  1126. FIGURE 12-2 Two types of syringes. A, Regular tip syringe. The regular tip is held in place by pressure, as seen in the 1-mL syringe. B, The Luer-Lok syringe has spirals to secure the needle, as seen on a larger 3-mL syringe.
  1127. TABLE 12-1 Commonly Used Intravenous Room Supplies
  1128. Needles
  1129. FIGURE 12-3 Tubex holders are intended to be reused. They hold the disposable Tubex or Carpuject cartridges. Each cartridge is prelabeled with the medication name, strength, volume, and concentration. The pharmacy stocks holders and cartridges.
  1130. FIGURE 12-4 Needle sizes shown are (from top to bottom) 19, 20, 21, 23, and 25 gauge. Technicians may use a 19-gauge needle for small volumes such as 1 mL or less. Larger gauges (not shown) include 18 and 16 gauge for larger volumes.
  1131. Filters
  1132. Stock Levels
  1133. FIGURE 12-5 Anatomy of a needle.
  1134. FIGURE 12-6 A, Mini-spikes used in multidose vials. B, Filter needles. C, Filter sizes. D, Ampules and ampule breakers. E, Transfer needle. F, Syringe and caps.
  1135.  Tech Note!
  1136. Routes of Administration (ROA)
  1137.  Tech Note!
  1138. Medication Delivery Systems
  1139. Piggyback Containers
  1140. FIGURE 12-7 This gravity pump system intravenous piggyback setup shows a 100-mL Viaflex container (left) piggybacked to a large-volume 1-L IV (right).
  1141. Large- and Small-Volume Drips
  1142. Buretrol Systems
  1143. FIGURE 12-8 Volutrol drip systems are used mostly for pediatric patients. Nurses prepare these.
  1144.  Tech Note!
  1145. Continuous Analgesic Delivery Systems
  1146. Patient-Controlled Analgesia (PCA) Syringe System
  1147. PCA Syringe Systems
  1148. Patient-Controlled Analgesia (PCA) Cassette System
  1149. FIGURE 12-9 A, Controlled analgesia device pump. B, Patient-controlled analgesia pump.
  1150. PCA Cassette Systems
  1151. Vials
  1152.  Tech Note!
  1153. Aseptic Technique
  1154. FIGURE 12-10 ADD-Vantage system: To prepare IV, follow the three steps listed. 1, Remove the vial top. 2, Pull up flange, removing the seal on the intravenous bag. 3, Screw the vial into the port. Do not break the seal between vial and bag.
  1155. FIGURE 12-11 Proper hand washing technique.
  1156. FIGURE 12-12 Steps for proper sterile gloving. 1, Open glove packet. 2, Open glove cover without touching gloves. 3, Holding cuff of glove, pull glove over hand. 4, Slide gloved hand under the cuff of the second glove. Carefully pull on glove.
  1157. BOX 12-2
  1158. Personnel Preparation*
  1159.  Tech Alert!
  1160. USP <797>
  1161. Risk Levels
  1162. TABLE 12-2 Terms/Abbreviations Used in Pharmacy
  1163. TABLE 12-3 USP <797> Risk Levels
  1164. Low Risk Level 1
  1165. Medium Risk Level 2
  1166. High Risk Level 3
  1167. Education and Training
  1168. FIGURE 12-13 Compounding evaluation checklist.
  1169. BOX 12-3
  1170. Media-Fill Tests
  1171.  Tech Note
  1172. Requirements for Compounding
  1173. TABLE 12-4 USP Air Standards Based on 0.5-µm Particle Size
  1174. IV Environment
  1175. BOX 12-4
  1176. Environment Terminology
  1177. Storage and Stability
  1178. FIGURE 12-14 Clean room.
  1179. Hood Cleaning and Maintenance
  1180. Airflow
  1181. TABLE 12-5 Storage Risk Levels: Temperature Ranges and Expiration Dates of Compounded Medications
  1182. Cleaning and Maintaining Hoods
  1183. TABLE 12-6 HEPA Filtering System Standards
  1184. BOX 12-5
  1185. Daily Cleaning of Laminar Airflow Workbench
  1186. Hand Placement
  1187. FIGURE 12-15 The six-step process of using aseptic technique in the hood is as follows: (1) Using alcohol, wipe the tops of the vials and the ports on the intravenous bags from back to front (wipe around the vial and bag rather than over or behind). (2) Place the needle bevel side up and push it into the rubber stopper of the vial. Preload the syringe with the necessary amount of air to replace solution. (3) Invert the vial and syringe 180 degrees. Push in the air from the syringe and pull out the solution. (4) After removing the syringe from the vial, insert the needle into the intravenous bag and inject the medication using a steady hand. (5) After injecting the intravenous bag with the medication, immediately flip the bag over. This decreases the possibility of forgetting which bags have been injected and which ones have not. (6) Never recap the used needles; instead, discard each syringe in a sharps container along with the uncapped needle after use. Syringes cannot be reused when changing from one drug to another. This decreases the chance of drug-to-drug contamination.
  1188. BOX 12-6
  1189. Cleaning the Vertical Flow Hood
  1190. BOX 12-7
  1191. Cleaning the Biological Safety Cabinet
  1192. Disposal
  1193.  Tech Note!
  1194. Spills
  1195.  Tech Note!
  1196. Parenteral Antibiotics and Solutions
  1197. BOX 12-8
  1198. BSC Guidelines for Medication Preparation
  1199. TABLE 12-7 Example of Suggested Dosing Times, Solutions, and Appropriate Volumes for Antibiotics
  1200. Technique
  1201. Use of Ampules to Prepare Medications
  1202. Technique
  1203. FIGURE 12-16 Proper manipulation of ampule: Ampule sizes range from 1- to 50-mL glass containers. For larger ampules, an ampule breaker is suggested. For smaller ampules, follow these steps: (1) Tap top of ampule to empty top of container. (2) Using an alcohol swab, wipe the neck of the ampule and snap open (away from you). (3) Tilt the ampule at an angle (the solution will not spill) and withdraw needed amount of drug using a filter needle. (4) Replace the filter needle with a regular needle and inject into solution; however, if sending the syringe, remove the needle and cap the end of the syringe. (5) Label container and place in proper location for pharmacist’s inspection.
  1204. Hyperalimentation
  1205.  Tech Note!
  1206. FIGURE 12-17 A total parenteral nutrition preparation connected to an infusion set.
  1207. Electrolytes and Additives
  1208. TABLE 12-8 Types of Parenteral Additives
  1209. FIGURE 12-18 Example of a total parenteral nutrition order.
  1210. Compatibility Considerations of Parenteral Medications
  1211.  Tech Note!
  1212. Components of a Label for Intravenous Medication
  1213. TABLE 12-9 Additional Considerations for the Preparation of Drugs
  1214. FIGURE 12-19 Example of an intravenous medication label.
  1215. Do You Remember These Key Points?
  1216. Review Questions
  1217. Multiple choice questions
  1218. True/False
  1219. Technician’s Corner
  1220. Bibliography
  1221. Websites
  1222. CHAPTER 13 Pharmacy Stock and Billing
  1223. Objectives
  1224. Terms and Definitions
  1225. Types of Insurance
  1226. Introduction
  1227. Formulary and Drug Utilization
  1228. Pharmacist’s Perspective
  1229. Drug Utilization and Formulary Selection Process
  1230. Generic versus Trade Name Drugs
  1231. Third-Party Billing
  1232. Point of Sale (POS) Billing
  1233. Types of Insurance
  1234. Health Maintenance Organization (HMO)
  1235. TABLE 13-1 Types of Insurance Claims
  1236. What If Your Patient Has HMO Insurance?
  1237. Preferred Provider Organization (PPO)
  1238. What If Your Patient Has PPO Insurance?
  1239. Drug Discount Cards or Drug Coupon Cards
  1240. Government-Managed Insurance Programs
  1241. History of Medicare and Medicaid
  1242. FIGURE 13-1 Sample health insurance card.
  1243. BOX 13-1
  1244. Medicare Coverage Types
  1245. TABLE 13-2 Chronological Changes in Medicare/Medicaid Coverage
  1246.  Tech Note!
  1247. Current Use of Medicare/Medicaid Insurance
  1248. Medicare
  1249. Medicare Part D
  1250. What If Your Patient Has Medicare Insurance?
  1251. BOX 13-2
  1252. Medigap Coverage
  1253. BOX 13-3
  1254. Various Supplies Covered by Medicare
  1255. FIGURE 13-2 Sample Medicare Part D card.
  1256. Medicaid
  1257. What If Your Patient Has Medicaid Insurance?
  1258. Workers’ Compensation
  1259.  Tech Note!
  1260. Billing the Insurance Company
  1261. Prior Authorization
  1262.  Tech Note!
  1263. TABLE 13-3 Minimum Information Required by Insurance Companies
  1264.  Tech Note!
  1265. Patient Profiles
  1266. FIGURE 13-3 TAR form.
  1267. FIGURE 13-4 Computer patient profile using OmniLinkRx.
  1268. BOX 13-4
  1269. Information Contained on a Prescription Card
  1270. Processing Claims
  1271. Claim Problems
  1272. FIGURE 13-5 Universal claim form.
  1273.  Tech Note!
  1274. Coverage Expiration Policy for Drugs
  1275. Limitation of Plan Exceeded
  1276. FIGURE 13-6 The arrow on the drug label shows the NDC code for this drug.
  1277.  Tech Note!
  1278. Handling Non-formulary Drugs or Noncovered National Drug Codes
  1279. Filling a Prescription Too Soon
  1280. Non-Identification Match
  1281. Pharmacy Stock
  1282. Ordering Systems
  1283. Special Orders
  1284. Bar Coding
  1285. Automated Dispensing Systems (ADS)
  1286.  Tech Note!
  1287. Manual Ordering
  1288. FIGURE 13-7 OmniRx.
  1289. New Stock
  1290.  Tech Note!
  1291. Proper Storage
  1292. Returns
  1293. BOX 13-5
  1294. Receiving Stock
  1295. Drug Recalls
  1296. Damaged Stock
  1297. Expired Stock
  1298. BOX 13-6
  1299. Recall Notification
  1300. Automated Return Companies
  1301. Nonreturnable Drugs and Their Disposal
  1302.  Tech Note!
  1303. Suppliers
  1304. Special Ordering Considerations
  1305. TABLE 13-4 Difference in Ordering from Manufacturers, Wholesalers, and Warehouse Repackaging Plants
  1306. Do You Remember These Key Points?
  1307. Review Questions
  1308. Multiple choice questions
  1309. True/False
  1310. Technician’s Corner
  1311. Bibliography
  1312. Websites
  1313. CHAPTER 14 Medication Safety and Error Prevention
  1314. Objectives
  1315. Terms and Definitions
  1316. Introduction
  1317. What Constitutes an Error?
  1318. TABLE 14-1 Common Hospital Pharmacy Errors (ASHP)
  1319. TABLE 14-2 MERP Error Categories
  1320. How Errors Occur
  1321. Scenario #1: Misinterpretation of Physician’s Orders
  1322. Scenario #2: Missed Dose
  1323. Scenario #3: Wrong Patient
  1324. Scenario #4: Adverse Effect
  1325. Scenario #5: Noncompliance
  1326. Where Errors Are Made
  1327. Why Errors Occur
  1328. BOX 14-1
  1329. Non–Health Care Settings
  1330. Recommendations from MERP
  1331. Example 1
  1332. Example 2
  1333. Look-Alike, Sound-Alike (LASA) Drugs
  1334. Look-Alike Drug Names/Tall Man Lettering
  1335. TABLE 14-3 Commonly Confused Drug Names
  1336. Drug Interactions as a Source of Error
  1337. Warfarin (Coumadin) Interactions
  1338. TABLE 14-4 Examples of Drug-Drug Interactions
  1339. Errors in the Pharmacy
  1340. TABLE 14-5 Example of Warfarin Interactions with Drugs, Supplements, and Foods
  1341. Documented Errors
  1342. Medication Errors That Involve Allergies
  1343. Parenteral Errors
  1344. Sustained Released (SR) Dosage Form Errors
  1345. Errors Related to Patient Care
  1346. Nosocomial Infections
  1347. Home Health Care Errors
  1348. Age-Related Errors
  1349. Medical Errors and the Elderly
  1350.  Tech Alert!
  1351. Medical Errors and Pediatric Patients
  1352. How to Stop Errors from Occurring
  1353. A Pharmacist’s Daily Routine
  1354. Computerized Prescription Order Entry (CPOE)
  1355. FIGURE 14-1 WPL305 desktop bar code printer.
  1356. Reporting Errors
  1357. BOX 14-2
  1358. Organizations that Track Errors
  1359. Verbal Ordering Error Prevention
  1360. Parenteral Medication Error Prevention
  1361. Common Pharmacy Technology
  1362. Bar Coding
  1363. Robot Rx Machines
  1364. FIGURE 14-2 Robot Rx machine.
  1365. Automated Dispensing Systems (ADS)
  1366. Community Pharmacy ADS Machines
  1367. FIGURE 14-3 KL20.
  1368. Patient Dose-Specific Orders
  1369. USP <797> Regulations
  1370. Drug Labeling
  1371. FIGURE 14-4 SP 200 robotic prescription dispensing system.
  1372. Boxed Warnings
  1373. Training and Education
  1374. ASHP
  1375. Medication Reconciliation
  1376. Other Considerations
  1377. FIGURE 14-5 Sample reconciliation form.
  1378. Do You Remember These Key Points?
  1379. BOX 14-3
  1380. Methods to Avoid Errors in the Pharmacy
  1381. Review Questions
  1382. Multiple choice questions
  1383. True/False
  1384. Technician’s Corner
  1385. Bibliography
  1386. Section Two Body Systems
  1387. CHAPTER 15 Endocrine System
  1388. Objectives
  1389. Terms and Definitions
  1390. COMMON DRUGS PRESCRIBED FOR HORMONAL CONDITIONS (NONINCLUSIVE LISTINGS)
  1391. MEDICAL TERMINOLOGY
  1392. Endocrine Anatomy
  1393. FIGURE 15-1 Endocrine anatomy.
  1394. TABLE 15-1 Endocrine Structures, Medical Terms, and Functions
  1395. Description of Hormones
  1396. Structure and Function of Hormones
  1397. FIGURE 15-2 Structures of a steroid and a protein molecule.
  1398. TABLE 15-2 Hormone Function
  1399. Mechanism of Action
  1400. Functions of the Endocrine Glands
  1401. Hypothalamus
  1402. Pineal Gland
  1403. Pituitary Gland
  1404. TABLE 15-3 Hormonal Production of Anterior and Posterior Pituitary Gland
  1405. Thyroid Gland
  1406. FIGURE 15-3 Thyroid and parathyroid glands.
  1407. Parathyroid Glands
  1408. Adrenal Glands
  1409. TABLE 15-4 Adrenal Hormones and Their Effects on the Body
  1410. FIGURE 15-4 Pancreas.
  1411. Pancreas
  1412. Ovaries
  1413. FIGURE 15-5 Ovaries.
  1414. FIGURE 15-6 Testes.
  1415. Testes
  1416. Conditions of the Endocrine System and Their Treatments
  1417. TABLE 15-5 Endocrine Conditions with Corresponding Glands and Hormones and Possible Treatments
  1418. Conditions of the Pituitary Gland and Hypothalamus and Their Treatments
  1419. Gigantism and Acromegaly
  1420. Prognosis
  1421. Non–Drug Treatment
  1422. Drug Treatment
  1423. Hypopituitarism
  1424. Prognosis
  1425. Non–Drug Treatment
  1426. Drug Treatment
  1427. Diabetes Insipidus
  1428. Prognosis
  1429. Non–Drug Treatment
  1430. Drug Treatment
  1431. Conditions of the Thyroid Gland and Their Treatment
  1432. Hyperthyroidism
  1433. Prognosis
  1434. Non–Drug Treatment
  1435. Drug Treatment
  1436. Hypothyroidism
  1437. Prognosis
  1438. Non–Drug Treatment
  1439. Drug Treatment
  1440. Conditions of the Parathyroid Glands and Their Treatment
  1441. Hyperparathyroidism
  1442. Prognosis
  1443. Non–Drug Treatment
  1444. Drug Treatment
  1445. Bone Metabolism Regulators
  1446. Bisphosphonates
  1447. Hypoparathyroidism
  1448. Prognosis
  1449. Non–Drug Treatment
  1450. Drug Treatment
  1451. Osteoporosis Management and Treatments
  1452. Osteoporosis
  1453. Prognosis
  1454. Non–Drug Treatments
  1455. Drug Treatments
  1456. Osteoporosis Prevention
  1457. Conditions of the Adrenal Glands and Their Treatment
  1458. Cushing’s Syndrome
  1459. Prognosis
  1460. Non–Drug Treatment
  1461. Drug Treatment
  1462. Addison’s Disease
  1463. Prognosis
  1464. Non–Drug Treatment
  1465. Drug Treatment
  1466. Mineralocorticoid
  1467. Glucocorticoids
  1468.  Tech Note!
  1469. Adrenal Medulla
  1470. Endocrine Conditions of the Pancreas Gland and Their Treatments
  1471. Diabetes Mellitus
  1472. Type 1
  1473. Type 2
  1474. Gestational Diabetes Mellitus (GDM)
  1475. Other Specific Types
  1476. Prognosis
  1477. Non–Drug Treatment
  1478. Drug Treatments
  1479.  Tech Alert!
  1480. FIGURE 15-7 A, Humulin R (fast-acting). B, Humulin L (intermediate-acting).
  1481. TABLE 15-6 Commonly Prescribed Insulins for Insulin-Dependent Diabetes Mellitus (All Are Given Subcutaneously)
  1482. TABLE 15-7 Antidiabetic Agents for Type 2 Diabetes Mellitus
  1483. TABLE 15-8 Combination Oral Agents
  1484. Combination Agents
  1485. Blood Glucose Meters
  1486. TABLE 15-9 Diagnostic Devices for Blood and Urine Analysis
  1487. Hormones Secreted by the Ovaries and Their Uses
  1488. TABLE 15-10 Examples of Alternate Routes of Administration of Estrogens
  1489. Conditions of the Testes and Their Treatment
  1490. Do You Remember These Key Points?
  1491. Review Questions
  1492. Multiple choice questions
  1493. True/False
  1494. Technician’s Corner
  1495. Bibliography
  1496. CHAPTER 16 Nervous System
  1497. Objectives
  1498. Terms and Definitions
  1499. COMMON DRUGS USED FOR CONDITIONS INVOLVING THE CENTRAL NERVOUS SYSTEM
  1500. NERVOUS SYSTEM MEDICAL TERMINOLOGY
  1501. The Nervous System
  1502. FIGURE 16-1 The nervous system is analogous to a mainframe computer (central nervous system) that communicates with other computers further away (peripheral nervous system).
  1503.  Tech Note!
  1504. The Neuron
  1505. TABLE 16-1 Neuronal Transmitters, Their Most Important Clinical Locations, and Some of Their Actions
  1506. FIGURE 16-2 The nervous system: Divisions include the somatic and autonomic branches. The somatic division sends and receives impulses to and from the muscles whereas the autonomic system regulates both sympathetic and parasympathetic systems.
  1507. Afferent (Sensory) Neurons
  1508. Efferent (Motor) Neurons
  1509.  Tech Note!
  1510. Nerve Transmission
  1511. FIGURE 16-3 Neuron: Impulses travel down the axon into the nerve terminal, where they are released into the synaptic space between each neuron. Impulses then are transmitted to the following neuron via the dendrites, which extend out of the cell body. The spaces between segments of the myelin sheath are known as the nodes of Ranvier.
  1512. FIGURE 16-4 The afferent and efferent nerves and the areas innervated by the sympathetic and parasympathetic systems. Preganglionic and postganglionic nerves that make up the cell bodies and axon are shown.
  1513. Central Nervous System
  1514. Brain
  1515. FIGURE 16-5 Neuronal impulse transfer cycle.
  1516. FIGURE 16-6 Lobes of the brain, cerebellum, and brainstem, which are all part of the central nervous system.
  1517. FIGURE 16-7 Cranial nerves.
  1518. Cranial Nerves
  1519. Spinal Cord
  1520. TABLE 16-2 Primary Functions of Cranial Nerves
  1521. FIGURE 16-8 Segments of the spinal cord.
  1522. Blood-Brain Barrier
  1523.  Tech Note!
  1524. Peripheral Nervous System (PNS)
  1525. TABLE 16-3 Permeability of the Blood-Brain Barrier
  1526. FIGURE 16-9 Lock-and-key mechanism: As the knee is tapped, impulses are sent to and from the brain. The neurotransmitters affect specific receptors that are interpreted. The reaction sent via neurotransmitters is to jerk the knee.
  1527.  Tech Note!
  1528. Autonomic System
  1529. Sympathetic System
  1530.  Tech Note!
  1531. Parasympathetic System
  1532. Somatic System
  1533. TABLE 16-4 Major Organ Response When Sympathetic System Is Activated
  1534. TABLE 16-5 Response of the Body Systems to Parasympathetic Stimulation
  1535.  Tech Note!
  1536. Neurotransmitters
  1537. Main Neurotransmitters
  1538.  Tech Note!
  1539. TABLE 16-6 α- and β-Receptors and Their Effects on the Body Systems
  1540. Adrenergic Agents and Adrenergic Blockers
  1541. Sympathomimetics or Adrenergic Agents
  1542.  Tech Note!
  1543. Cholinergic Agents and Cholinergic Blockers
  1544. Conditions of the Nervous System and Their Treatments
  1545. BOX 16-1
  1546. Conditions/Diseases Affecting the Nervous System and Websites for Additional Information
  1547. Disorders and Stroke
  1548. Government Institutes
  1549. General Nervous System Disorders
  1550. Skeletal Muscle Pain
  1551. Central-Acting Medications
  1552. Smooth Skeletal Muscle Relaxants
  1553. Direct-Acting Agents
  1554. Muscle Relaxants with Analgesics/Antiinflammatories
  1555. Specific Conditions Affecting the Peripheral Nervous System
  1556. Bell’s Palsy
  1557. Prognosis
  1558. Non–Drug Treatment
  1559. Drug Treatment
  1560. Myasthenia Gravis (MG)
  1561. Prognosis
  1562. Non–Drug Treatment
  1563. Drug Treatments
  1564. Cholinergic Agents
  1565. Disorders of the Brain and/or Spinal Cord
  1566. Stroke
  1567. Prognosis
  1568. Non–Drug Treatment
  1569. Drug Treatment
  1570. Anticoagulant
  1571. Antiplatelet
  1572.  Tech Note!
  1573. Migraine Headache
  1574. Prognosis
  1575. Non–Drug Treatment
  1576. TABLE 16-7 Types of Migraines
  1577. Drug Treatments
  1578. TABLE 16-8 Migraine Medications
  1579. Pharmacist’s Perspective
  1580. What’s New in Headache Management?
  1581. Epilepsy
  1582. Prognosis
  1583. BOX 16-2
  1584. Types of Seizures
  1585. Partial Seizures
  1586. Generalized Seizures
  1587. Non–Drug Treatment
  1588. Drug Treatments
  1589. TABLE 16-9 Agents Used for Treatment of Epilepsy
  1590. Examples of Anticonvulsants
  1591. Hydantoin Anticonvulsants
  1592. Succinimide Anticonvulsant
  1593.  Tech Note!
  1594. Barbiturates (Controlled Substances)
  1595. Benzodiazepines (Controlled Substances)
  1596. Alzheimer’s Disease
  1597. Prognosis
  1598. Non–Drug Treatment
  1599. Drug Treatment
  1600. BOX 16-3
  1601. Stages Associated with Alzheimer’s Disease
  1602. Cholinesterase Inhibitors
  1603.  Tech Note!
  1604. Multiple Sclerosis (MS)
  1605. FIGURE 16-10 Multiple sclerosis lesions in the brain and brainstem.
  1606. Prognosis
  1607. Non–Drug Treatment
  1608. Drug Treatment
  1609. ABRC Agents
  1610. Interferons
  1611. Antispasmodic Medication
  1612. Central-Acting Smooth Muscle Relaxant; Antispasmodic
  1613. Parkinson’s Disease
  1614. Prognosis
  1615. Non–Drug Treatment
  1616. FIGURE 16-11 Symptoms and signs of Parkinson’s disease.
  1617. Drug Treatment
  1618. TABLE 16-10 Medications Used to Treat Parkinson’s Disease
  1619. Examples of Anti-Parkinsonism Drugs
  1620. Selective MAO-B Inhibitor
  1621. Anticholinergics Prolong the Effects of Dopamine by Inhibiting the Reuptake Mechanism
  1622. Dopamine Agonists
  1623. Amyotrophic Lateral Sclerosis (ALS)
  1624. Prognosis
  1625. Non–Drug Treatment
  1626. Drug Treatment
  1627. Dystonia
  1628. Prognosis
  1629. Non–Drug Treatment
  1630. Drug Treatment
  1631.  Tech Note!
  1632. Tourette’s Syndrome (TS)
  1633. BOX 16-4
  1634. Medications Used to Treat Dystonia
  1635. Agents That Reduce Levels of Acetylcholine
  1636. Dopamine-Stimulating Agents
  1637. Agents That Regulate GABA
  1638. Miscellaneous Agents Used for the Following Symptoms:
  1639. Insomnia
  1640. Spasms
  1641. Pain
  1642. Prognosis
  1643. Non–Drug Treatment
  1644. Drug Treatment
  1645. TABLE 16-11 Medications Used for Treatment of Tourette’s Tics
  1646. Butyrophenone
  1647. Miscellaneous Muscle Agents
  1648. Neuromuscular Blockers
  1649. BOX 16-5
  1650. Classification of Neuromuscular Blockers
  1651. Short-Acting (Effective 20-26 min)
  1652. Intermediate-Acting
  1653. Long-Acting (Effective 75-100 min)
  1654. BOX 16-6
  1655. Medications Used for Conscious Sedation
  1656. Possible Combinations for Adults
  1657. Possible Combinations for Children
  1658. Conscious Sedation
  1659.  Tech Alert!
  1660. Do You Remember These Key Points?
  1661. Review Questions
  1662. Multiple choice questions
  1663. True/False
  1664. Technician’s Corner
  1665. Bibliography
  1666. Websites Referenced
  1667. CHAPTER 17 Psychopharmacology
  1668. Objectives
  1669. Terms and Definitions
  1670. COMMON DRUGS USED FOR PSYCHOTHERAPEUTIC CONDITIONS
  1671. PSYCHOPHARMACOLOGY TERMINOLOGY
  1672. TABLE 17-1 Types of Mental Disorders
  1673. TABLE 17-2 Mental Health Websites
  1674. Emotional Health
  1675. Psychiatric Disorders
  1676. Non–Drug Treatments
  1677.  Tech Note!
  1678. General Psychiatric Disorders
  1679. Depression
  1680. Prognosis
  1681. Non–Drug Treatment
  1682. Drug Treatments
  1683. Antidepressants
  1684. Selective Serotonin Reuptake Inhibitors
  1685. Selective Serotonin Reuptake Inhibitors (SSRIs)
  1686. Serotonin Norepinephrine Reuptake Inhibitors
  1687. Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
  1688. Tricyclic Antidepressants
  1689. Tricyclic Antidepressants
  1690. TABLE 17-3 Examples of Foods That Contain Tyramine
  1691. Monoamine Oxidase Inhibitors (MAOIs)
  1692. Monoamine Oxidase Inhibitors (MAOIs)
  1693. Additional Antidepressants
  1694. Other Antidepressants
  1695. Anxiety Disorders
  1696. Prognosis
  1697. Non–Drug Treatments
  1698. Drug Treatments
  1699. TABLE 17-4 Examples of Types of Phobias
  1700. TABLE 17-5 Types of Obsessive-Compulsive Personality Disorders
  1701. Antianxiety Medications
  1702. Bipolar Disorder
  1703. Prognosis
  1704. Non–Drug Treatment
  1705. Drug Treatment
  1706. Antimanics
  1707. Schizophrenia
  1708. Prognosis
  1709. Non–Drug Treatments
  1710. Drug Treatments
  1711. TABLE 17-6 Common Agents Used to Treat Schizophrenia
  1712. Typical Antipsychotics
  1713. Phenothiazines
  1714. Atypical Antipsychotics
  1715. Atypical Antipsychotics
  1716. TABLE 17-7 Types and Description of Insomnia
  1717. Other Conditions
  1718. Insomnia
  1719. Prognosis
  1720. Non–Drug Treatment
  1721. Drug Treatment
  1722. TABLE 17-8 Common (Adult Dosages) Over-the-Counter Medications Indicated For Insomnia
  1723.  Tech Note!
  1724. Benzodiazepines.
  1725. Benzodiazepine Hypnotics
  1726. Non-benzodiazepines.
  1727. Non-Benzodiazepine Hypnotics
  1728. Barbiturates.
  1729. Side Effects
  1730. TABLE 17-9 Common Barbiturates
  1731. Barbiturates
  1732. Attention Deficit/Hyperactivity Disorder (ADHD)
  1733. Prognosis
  1734. Non–Drug Treatment
  1735. Drug Treatment
  1736. TABLE 17-10 Agents Used to Treat ADD/ADHD. (Most products are for use in children >6 yr.; some extended-release products not acceptable for young children)
  1737. Medications and the Elderly
  1738. Do You Remember These Key Points?
  1739. Review Questions
  1740. Multiple choice questions
  1741. True/False
  1742. Technician’s Corner
  1743. Bibliography
  1744. Websites
  1745. CHAPTER 18 Respiratory System
  1746. Objectives
  1747. Terms and Definitions
  1748. COMMON DRUGS USED FOR RESPIRATORY CONDITIONS
  1749. FIGURE 18-1 Diagram of respiratory system.
  1750. RESPIRATORY TERMINOLOGY
  1751. Structure and Function of the Respiratory System
  1752.  Tech Note!
  1753. Upper Respiratory System
  1754. Lower Respiratory System
  1755. FIGURE 18-2 Bronchial tree.
  1756. Respiration
  1757. Exchange of Gases
  1758. FIGURE 18-3 Exchange of oxygen and carbon dioxide.
  1759.  Tech Note!
  1760. Breathing
  1761.  Tech Note!
  1762. Sneezing
  1763. Disorders/Conditions of the Respiratory System
  1764. Upper Respiratory System
  1765. TABLE 18-1 Types of Breathing Dysfunction
  1766. TABLE 18-2 Conditions of the Upper Respiratory System
  1767. Common Cold
  1768. Prognosis
  1769. Non–Drug Treatment
  1770. Drug Treatment
  1771. Relief of Sore Throat
  1772. Local Anesthetics for Throat Pain
  1773. BOX 18-1
  1774. Examples of Conditions that May be Affected by OTC Medications
  1775. TABLE 18-3 Combination Agents Sold OTC for Symptoms of Colds, Hay Fever, Allergies, Flu, and Respiratory Tract Infections
  1776. Antitussives (Reduce Coughing)
  1777. Narcotic Antitussive/Expectorant
  1778. Expectorants (Promote Coughing)
  1779. Expectorant (OTC)
  1780. Nasal Decongestants (Sympathomimetics)
  1781. Decongestants (OTC)
  1782. Laryngitis
  1783. Prognosis
  1784. Non–Drug Treatment
  1785. Drug Treatment
  1786. Influenza
  1787. Prognosis
  1788. Non–Drug Treatment
  1789. FIGURE 18-4 Influenza.
  1790. Drug Treatment
  1791. H1N1 (Swine Flu)
  1792. Prognosis
  1793. Non–Drug Treatment
  1794. BOX 18-2
  1795. Vaccinations (Prevention Guidelines)
  1796. Drug Treatment
  1797. Rhinitis
  1798. Prognosis
  1799. Non–Drug Treatments
  1800. Drug Treatments
  1801. Rx Nasal Corticosteroids
  1802. Allergies
  1803. Prognosis
  1804. Non–Drug Treatment
  1805. Drug Treatments
  1806. OTC Antihistamines
  1807. Nonsedating Rx Antihistamines
  1808. TABLE 18-4 Agents Used for the Treatment of Allergies
  1809. Nonsedating OTC Antihistamines
  1810. Low-Sedating OTC Antihistamines
  1811. Lower Respiratory System
  1812. TABLE 18-5 Conditions of the Lower Respiratory System
  1813.  Tech Note!
  1814. Pneumonia
  1815. Prognosis
  1816. Non–Drug Treatment
  1817. Drug Treatment
  1818. Bacterial Vaccines
  1819. Viral Vaccines
  1820. Asthma
  1821. Prognosis
  1822. Non–Drug Treatments
  1823. Drug Treatments
  1824. Corticosteroids
  1825. FIGURE 18-5 Asthma obstruction.
  1826. FIGURE 18-6 A, Proper use of an inhaler. B, Inhaler with spacer (e.g., AeroChamber).
  1827. Long-Acting Bronchodilators
  1828. Combination: Long-Acting Bronchodilator/Steroid Inhaler
  1829. Leukotriene Receptor Antagonists (Leukotriene Inhibitors)
  1830. Mast Cell Stabilizers
  1831. Medications for Acute Asthma Attacks
  1832.  Tech Note!
  1833. Chronic Obstructive Pulmonary Disease (COPD)
  1834. BOX 18-3
  1835. Lung Diseases That Can Lead to COPD
  1836. Prognosis
  1837. Non–Drug Treatment
  1838. Drug Treatment
  1839. Corticosteroid/Long-Acting Bronchodilator Combinations
  1840. Methylxanthine Bronchodilators
  1841. Anticholinergics
  1842. Tuberculosis
  1843. Prognosis
  1844. FIGURE 18-7 Positive result of a tuberculosis test.
  1845. Non–Drug Treatment
  1846. Drug Treatment
  1847. Antituberculosis Agents
  1848. TABLE 18-6 Examples of Tuberculosis Regimens
  1849. Emergency Disorders of the Lungs
  1850. FIGURE 18-8 Pneumothorax.
  1851. Mucolytics
  1852. Mucolytic
  1853.  Tech Alert!
  1854. Do You Remember These Key Points?
  1855. Review Questions
  1856. Multiple choice questions
  1857. True/False
  1858. Technician’s Corner
  1859. Bibliography
  1860. Websites
  1861. CHAPTER 19 Visual and Auditory Systems
  1862. Objectives
  1863. Terms and Definitions: Eye
  1864. Terms and Definitions: Ear
  1865. COMMON DRUGS USED FOR CONDITIONS OF THE EYE
  1866. The Eyes (Ophthalmic System)
  1867. MEDICAL TERMS AND CONDITIONS OF THE EYE
  1868. Anatomy of the Eye
  1869. FIGURE 19-1 Anatomy of the eye.
  1870. FIGURE 19-2 Eye muscles and direction of movement. Superior rectus rotates upward and inward; inferior rectus rotates downward and inward; medial rectus rotates inward; lateral rectus rotates outward; superior oblique rotates downward and outward; inferior oblique rotates upward and outward.
  1871.  Tech Note!
  1872. Vision
  1873. Conditions That Affect the Eye
  1874. Common Conditions
  1875. Allergies
  1876. BOX 19-1
  1877. Abbreviations
  1878. Terms
  1879. Abbreviations That Should NOT Be Used*
  1880. Prognosis
  1881. Non–Drug Treatment
  1882. Drug Treatments
  1883. TABLE 19-1 Ophthalmic Decongestants, Antihistamines, and Mast Cell Stabilizers*
  1884. Antiallergy Agents
  1885. Inflammation Caused by Infection or Injury
  1886. Corticosteroids
  1887. Antiinflammatory, Corticosteroids
  1888. BOX 19-2
  1889. Main Treatments for Inflammation and Infection
  1890. Nonsteroidal Antiinflammatory Drugs (NSAIDs)
  1891. Conjunctivitis
  1892. Prognosis
  1893. Non–Drug Treatment
  1894. Drug Treatment
  1895. Antiinfective Agents
  1896. Ophthalmic Sulfonamides
  1897. TABLE 19-2 Antiinfective Combination Ophthalmics
  1898. Aminoglycosides
  1899. TABLE 19-3 Viral/Nonviral Conjunctivitis
  1900. Macrolides
  1901. Antifungals
  1902.  Tech Note!
  1903. Antivirals
  1904. Cataracts
  1905. TABLE 19-4 Types of Cataracts
  1906. Prognosis
  1907. Non–Drug Treatment
  1908. Drug Treatment
  1909. TABLE 19-5 Commonly Used Agents for the Treatment of Glaucoma
  1910. Anticholinergics
  1911. Cholinergics—Miotics
  1912. Glaucoma
  1913. Prognosis
  1914. Non–Drug Treatment
  1915. Drug Treatment
  1916. BOX 19-3
  1917. Types of Glaucoma*
  1918. Primary (Includes Angle-Closure or Open-Angle Conditions)
  1919. Secondary
  1920. Congenital
  1921. Beta-Adrenergic Blockers
  1922. Carbonic Anhydrase Inhibitors
  1923. Carbonic Anhydrase Inhibitor—Oral
  1924. Miotics
  1925. Cholinergics—Miotics
  1926. Sympathomimetics
  1927. Prostaglandin Agonists
  1928.  Tech Note!
  1929. Blindness
  1930. Prognosis
  1931. Non–Drug Treatment
  1932. TABLE 19-6 Causes of Blindness
  1933. BOX 19-4
  1934. Proper Use of Eye Drops
  1935. Drug Treatment
  1936. Miscellaneous Ophthalmic Agents
  1937. The Ears (Auditory System)
  1938. COMMON DRUGS USED FOR CONDITIONS OF THE EAR
  1939. MEDICAL TERMS AND CONDITIONS OF THE EAR
  1940. TABLE 19-7 Artificial Tear Products
  1941. FIGURE 19-3 Anatomy of the ear.
  1942. Anatomy of the Ear
  1943. External Ear
  1944. Middle Ear
  1945. Inner Ear
  1946.  Tech Note!
  1947. Conditions Affecting the Ear
  1948. FIGURE 19-4 Anatomy of the inner ear.
  1949. BOX 19-5
  1950. Three Main Areas of the Inner Ear and Their Functions
  1951. Cochlea
  1952. Vestibule
  1953. Semicircular Canals
  1954. TABLE 19-8 Hearing Conditions
  1955. TABLE 19-9 Ear Preparations*
  1956. TABLE 19-10 Major Ingredients in Otic Preparations
  1957. TABLE 19-11 Combination Otics
  1958. Deafness
  1959. Prognosis
  1960. Non–Drug Treatment
  1961. Drug Treatment
  1962. Otitis Media
  1963. Prognosis
  1964. Non–Drug Treatment
  1965. Drug Treatment
  1966. Oral Antibiotics (Systemic)
  1967. Otic Antibiotics
  1968. Cerumen Buildup
  1969. Prognosis
  1970. Non–Drug Treatment
  1971. Drug Treatment
  1972. Ototoxicity
  1973. TABLE 19-12 Medications That Cause Ototoxicity or Tinnitus
  1974. Prognosis
  1975. Non–Drug Treatment
  1976. Drug Treatment
  1977. Steroid and Antibiotic Combination
  1978. Miscellaneous Otic Preparation
  1979.  Tech Note!
  1980. Miscellaneous Otic Preparations
  1981.  Tech Alert!
  1982. Do You Remember These Key Points?
  1983. Review Questions
  1984. Multiple choice questions
  1985. True/False
  1986. Technician’s Corner
  1987. Bibliography
  1988. Websites
  1989. CHAPTER 20 Integumentary System
  1990. Objectives
  1991. Terms and Definitions
  1992. COMMON DRUGS USED FOR SKIN CONDITIONS
  1993. MEDICAL TERMS AND CONDITIONS OF THE SKIN
  1994. Skin Anatomy
  1995. Hair and Nails
  1996. FIGURE 20-1 Skin anatomy.
  1997. Glands
  1998. Conditions Affecting the Skin, Hair, and Glands
  1999. FIGURE 20-2 Nail anatomy.
  2000. FIGURE 20-3 Glands of the skin.
  2001. Noninfectious Skin Conditions
  2002. Acne Vulgaris
  2003. FIGURE 20-4 Acne.
  2004. Prognosis
  2005. Non–Drug Treatment
  2006. TABLE 20-1 Topical Acne Treatments
  2007. Drug Treatments
  2008. Sunburn
  2009. TABLE 20-2 Skin Protection Factor Guide Coverage of Sunscreen*
  2010. Prognosis
  2011. Non–Drug Treatments
  2012. Choosing a Sunscreen
  2013. Drug Treatments
  2014. TABLE 20-3 Choosing a Sunscreen*
  2015. Urticaria
  2016. Prognosis
  2017. Non–Drug Treatment
  2018. Drug Treatment
  2019. TABLE 20-4 Examples of Topical Antiinflammatory Products
  2020. Skin Cancer
  2021. Prognosis
  2022. Non–Drug Treatment
  2023. Drug Treatment
  2024. FIGURE 20-5 Types of skin cancer: A, Squamous cell; B, Basal cell; C, Malignant melanoma.
  2025. BOX 20-1
  2026. Detection of Possible Skin Cancer
  2027. A—Asymmetry
  2028. B—Border
  2029. C—Color
  2030. D—Difference
  2031. BOX 20-2
  2032. Cancer Treatments
  2033. Surgery
  2034. Medication
  2035. Stasis Dermatitis and Ulcers
  2036. FIGURE 20-6 Ulceration.
  2037. TABLE 20-5 Examples of Topical Antibacterial Products
  2038. Prognosis
  2039. Non–Drug Treatment
  2040. Drug Treatment
  2041. Psoriasis
  2042. Prognosis
  2043. FIGURE 20-7 Psoriasis.
  2044. Non–Drug Treatment
  2045. Drug Treatment
  2046. TABLE 20-6 Agents Used to Treat Psoriasis (Most Are Rx)
  2047. Corticosteroids
  2048. Immunomodulators
  2049. Vitamin D Analog
  2050. Burns
  2051. Prognosis
  2052. BOX 20-3
  2053. Burn Degrees
  2054. FIGURE 20-8 Third-degree burn.
  2055. Non–Drug Treatment
  2056. Drug Treatment
  2057. Canker Sores
  2058. Prognosis
  2059. Non–Drug Treatment
  2060. Drug Treatment
  2061. TABLE 20-7 Canker Sore Treatments
  2062. Infectious Inflammatory Skin Conditions
  2063. Warts
  2064. Prognosis
  2065. FIGURE 20-9 A, HPV (common warts). B, Genital warts, male. C, Genital warts, female.
  2066. TABLE 20-8 Over-the-Counter (OTC) Products to Treat Common Warts
  2067. Non–Drug Treatment
  2068. Drug Treatment
  2069. Genital Warts
  2070.  Tech Note!
  2071. Athlete’s Foot
  2072. Prognosis
  2073. Non–Drug Treatment
  2074. FIGURE 20-10 A, Tina capitis (head). B, Tina pedis (athlete’s foot).
  2075. Drug Treatment
  2076. TABLE 20-9 Antifungal Products to Treat Athlete’s Foot
  2077. Herpes
  2078. Prognosis
  2079. FIGURE 20-11 Herpes simplex.
  2080. Non–Drug Treatment
  2081. Drug Treatment
  2082. TABLE 20-10 Herpes Medications
  2083. Impetigo
  2084. Prognosis
  2085. Non–Drug Treatment
  2086. Drug Treatment
  2087. Conditions of the Hair
  2088. Lice
  2089. FIGURE 20-12 A, Head louse. B, Crab lice.
  2090. Prognosis
  2091. Non–Drug Treatment
  2092. Drug Treatment
  2093. Conditions of the Nail
  2094. Acute Paronychia and Onychomycosis
  2095. Prognosis
  2096. Non–Drug Treatment
  2097. Drug Treatment
  2098. BOX 20-4
  2099. Nail Conditions
  2100.  Tech Note!
  2101. Do You Remember These Key Points?
  2102. Review Questions
  2103. Multiple choice questions
  2104. True/False
  2105. Bibliography
  2106. Websites
  2107. CHAPTER 21 Gastrointestinal System
  2108. Objectives
  2109. Terms and Definitions
  2110. COMMON DRUGS FOR THE GASTROINTESTINAL SYSTEM
  2111. GASTROINTESTINAL MEDICAL TERMINOLOGY
  2112. Form and Function of the Gastrointestinal System
  2113. Anatomy of the Gastrointestinal System
  2114. FIGURE 21-1 Anatomy of the gastrointestinal system (including mouth, pharynx, esophagus, stomach, and intestines).
  2115. FIGURE 21-2 Major glands of the mouth.
  2116. Ingestion
  2117.  Tech Note!
  2118. FIGURE 21-3 pH scale ranges from 1 (the most acidic) to 14 (the most basic). Normal human blood is pH 7.4, approximately the midpoint of the range.
  2119. Absorption
  2120. FIGURE 21-4 Intestinal tract (including duodenum, jejunum, and ileum).
  2121. TABLE 21-1 Foods and Enzymes That Digest Them
  2122. Excretion
  2123. Auxiliary Organ Functions
  2124. Conditions Affecting the Gastrointestinal System
  2125. TABLE 21-2 Conditions of the Upper/Lower GI System
  2126. Mouth and Throat Conditions
  2127.  Tech Note!
  2128. Stomach Conditions
  2129.  Tech Note!
  2130. GERD
  2131. TABLE 21-3 Gastrointestinal Conditions
  2132. TABLE 21-4 Over-the-Counter Antacid Agents (Single Ingredient)
  2133. Prognosis
  2134. Non–Drug Treatments
  2135. Drug Treatments
  2136. Antacids
  2137.  Tech Note!
  2138. Histamine2-Antagonists
  2139. TABLE 21-5 Over-the-Counter Combination Antacids
  2140. Proton Pump Inhibitors (PPIs)
  2141.  Tech Note!
  2142. Peptic Ulcer Disease (PUD)
  2143. Prognosis
  2144. Non–Drug Treatment
  2145. Drug Treatments
  2146. Intestinal Conditions
  2147. TABLE 21-6 Diagnostic Tests to Confirm Helicobacter pylori
  2148. TABLE 21-7 Helicobacter pylori Regimens
  2149. Diarrhea
  2150. Prognosis
  2151. Non–Drug Treatments
  2152. Drug Treatments
  2153. BOX 21-1
  2154. Bowel Problems
  2155. Constipation
  2156. Prognosis
  2157. Non–Drug Treatments
  2158. Drug Treatments
  2159.  Tech Note!
  2160. Bulk-Forming Laxatives
  2161. TABLE 21-8 Laxatives
  2162. Emollient Laxatives (Stool Softeners)
  2163. Stimulant Laxatives
  2164. Hyperosmolar Laxatives
  2165. Selective Chloride Channel Activators
  2166. Flatulence
  2167. Prognosis
  2168. Non–Drug Treatment
  2169. Drug Treatment
  2170. Antiflatulence Medications
  2171. TABLE 21-9 Over-the-Counter Combination Antacid-Antiflatulence Agents
  2172. Irritable Bowel Syndrome (IBS)
  2173. Prognosis
  2174. Non–Drug Treatment
  2175. Drug Treatment
  2176. Antispasmodics
  2177. Serotonin
  2178. Crohn’s Disease
  2179. Prognosis
  2180. Non–Drug Treatment
  2181. Drug Treatment
  2182. Biological Agents
  2183. Ulcerative Colitis
  2184. Prognosis
  2185. Non–Drug Treatment
  2186. Drug Treatment
  2187. Antiinflammatory
  2188. Emesis
  2189. Prognosis
  2190. Non–Drug Treatments
  2191. BOX 21-2
  2192. Variations of Emesis
  2193. Drug Treatments
  2194. Antidopaminergics
  2195. Phenothiazines
  2196. Miscellaneous Antiemetics
  2197. Serotonin Receptor Antagonists (5-HT3-Antagonists)
  2198. Antihistamines/Anticholinergics
  2199. Miscellaneous Conditions
  2200. Poisoning
  2201. TABLE 21-10 Antidotes
  2202. BOX 21-3
  2203. Poisonous Snakes and Spiders
  2204. Types of Snakes
  2205. Types of Spiders
  2206. Prognosis
  2207. Non–Drug Treatment
  2208. Drug Treatment
  2209. Lavage
  2210. Ipecac Syrup
  2211.  Tech Alert!
  2212. Activated Charcoal
  2213.  Tech Alert!
  2214. General Information
  2215. Do You Remember These Key Points?
  2216. Review Questions
  2217. Multiple choice questions
  2218. True/False
  2219. Technician’s Corner
  2220. Bibliography
  2221. Websites
  2222. CHAPTER 22 Urinary System
  2223. Objectives
  2224. Terms and Definitions
  2225. COMMON DRUGS FOR THE URINARY SYSTEM
  2226. URINARY MEDICAL TERMINOLOGY
  2227. Anatomy
  2228. Function of the Kidneys
  2229. FIGURE 22-1 Anatomy of urinary tract and nephrons.
  2230. Nephron Function
  2231. FIGURE 22-2 Anatomy of the kidney.
  2232. FIGURE 22-3 Nephron anatomy.
  2233.  Tech Note!
  2234. Tubular Reabsorption
  2235. FIGURE 22-4 Tubular reabsorption and secretion.
  2236. Tubular Secretion
  2237. FIGURE 22-5 Also known as an osmotic gradient, the smaller water molecules gravitate toward the highly concentrated sodium ions.
  2238. The Importance of Electrolytes
  2239. Conditions Affecting the Urinary System
  2240. Common Conditions
  2241. Renal Failure
  2242. TABLE 22-1 Conditions Affecting the Urinary System
  2243. TABLE 22-2 End-Stage Renal Disease Symptoms*
  2244. Prognosis
  2245. Non–Drug Treatment
  2246. FIGURE 22-6 Two types of dialysis.
  2247. Drug Treatment
  2248. Iron Supplement
  2249. Red Blood Cell Stimulators
  2250. Phosphorus Binding Agents
  2251. Agent to Reduce Risk of Renal Osteodystrophy (Weak Bones)
  2252. Edema
  2253. BOX 22-1
  2254. Some Causes of Edema
  2255. FIGURE 22-7 Pitting edema.
  2256. Prognosis
  2257. Non–Drug Treatment
  2258. Drug Treatment
  2259. Thiazides and Thiazide-like Agents
  2260.  Tech Alert!
  2261. Loop Diuretics
  2262. Potassium-Sparing Agents
  2263. TABLE 22-3 Combination Diuretics (Potassium-Sparing)
  2264. Potassium-Sparing Diuretics
  2265. Carbonic Anhydrase Inhibitors
  2266. Carbonic Anhydrase Inhibitor
  2267. Osmotic Diuretics
  2268.  Tech Alert!
  2269. Kidney Stones
  2270. Prognosis
  2271. Non–Drug Treatment
  2272. FIGURE 22-8 Common locations of kidney stones.
  2273. TABLE 22-4 Kidney Stones: Characteristics and Treatments
  2274. Drug Treatments
  2275. Urinary Tract Infection (UTI)
  2276. Prognosis
  2277. Non–Drug Treatment
  2278. Drug Treatment
  2279. Antiinfective Antibiotic
  2280.  Tech Note!
  2281. Uti Antibiotic
  2282. TABLE 22-5 Treatments for Urinary Tract Infections* (Based on Oral Adult Dosages Unless Otherwise Indicated)
  2283. Cephalosporin Antibiotic
  2284. Prostatitis
  2285. Prognosis
  2286. Non–Drug Treatment
  2287. Drug Treatment
  2288. Incontinence
  2289. TABLE 22-6 Drugs Commonly Used to Treat Bacterial Prostatitis
  2290. TABLE 22-7 Types of Urinary Incontinence
  2291. Prognosis
  2292. Non–Drug Treatment
  2293. Drug Treatment
  2294. Anticholinergic
  2295.  Tech Alert!
  2296. Do You Remember These Key Points?
  2297. Review Questions
  2298. Multiple choice questions
  2299. True/False
  2300. Technician’s Corner
  2301. Question
  2302. Bibliography
  2303. Websites
  2304. CHAPTER 23 Cardiovascular System
  2305. Objectives
  2306. Terms and Definitions
  2307. EXAMPLES OF CARDIOVASCULAR AGENTS
  2308. MEDICAL TERMINOLOGY OF THE CARDIOVASCULAR SYSTEM
  2309. Anatomy of the Heart
  2310. FIGURE 23-1 Anatomy of the heart.
  2311. FIGURE 23-2 Blood oxygenation.
  2312. Oxygenation
  2313. Cardiac Conduction System
  2314. The Cardiac Cycle
  2315. Conditions Affecting the Heart
  2316. FIGURE 23-3 Circulation of blood through the body.
  2317. Common Conditions
  2318. Hypertension
  2319. BOX 23-1
  2320. Common Conditions and Definitions
  2321. TABLE 23-1 Drug Classifications
  2322. Prognosis
  2323. Non–Drug Treatment
  2324. TABLE 23-2 Classifications of Combination Drugs
  2325. BOX 23-2
  2326. Examples of Conditions that Can Lead to Hypertension
  2327. Common Conditions or Factors That May Increase Risk for Hypertension
  2328. Risk Factors for Essential Hypertension
  2329. Drug Treatment
  2330. BOX 23-3
  2331. Classification of Blood Pressure Measurements
  2332. BOX 23-4
  2333. Approaches to Controlling High Blood Pressure
  2334. TABLE 23-3 Examples of Combination Drugs
  2335. Hypotension
  2336. Prognosis
  2337. Non–Drug Treatment
  2338. BOX 23-5
  2339. Types of Hypotension
  2340. BOX 23-6
  2341. Causes of Hypotension
  2342. Drug Treatment
  2343. Hyperlipidemia
  2344. Prognosis
  2345. Non–Drug Treatment
  2346. Drug Treatment
  2347. BOX 23-7
  2348. U.S. Guidelines for Cholesterol Measurements
  2349. Antihyperlipidemics
  2350. Bile Acid Sequestrants
  2351. HMG-CoA Reductase Inhibitors (“Statins”)
  2352. Fibric Acid Antihyperlipidemic
  2353. Cholesterol Absorption Inhibitor
  2354. Miscellaneous Antihyperlipidemic
  2355. Transient Ischemic Attacks (TIAs) and Strokes
  2356. Prognosis
  2357. Non–Drug Treatment
  2358. Drug Treatment
  2359. Calcium Channel Blocker
  2360.  Tech Alert!
  2361. Angina Pectoris
  2362. Prognosis
  2363. Non–Drug Treatment
  2364. Drug Treatment
  2365. Nitrates
  2366. FIGURE 23-4 Nitroglycerin sublingual tablet prescription.
  2367. TABLE 23-4 Common Nitrate Agents
  2368.  Tech Note!
  2369.  Tech Note!
  2370. Myocardial Infarction (MI)
  2371. Prognosis
  2372. Non–Drug Treatment
  2373. Drug Treatment
  2374. Arrhythmia
  2375. Prognosis
  2376. Non–Drug Treatment
  2377. Drug Treatment
  2378. Drug Action
  2379.  Tech Note!
  2380. Antiarrhythmics
  2381. Congestive Heart Failure (CHF)
  2382. Prognosis
  2383. Non–Drug Treatment
  2384. Drug Treatment
  2385. Cardiac Glycoside
  2386.  Tech Note!
  2387. Diuretics Used for Congestive Heart Failure–Related Edema
  2388. Thiazide and Thiazide-Like Diuretics
  2389. Loop Diuretics
  2390. BOX 23-8
  2391. Classification of Diuretic Agents
  2392. Loop Diuretics
  2393. Potassium-Sparing Diuretics
  2394. Potassium-Sparing Diuretic
  2395. Carbonic Anhydrase Inhibitors
  2396. Carbonic Anhydrase Inhibitor
  2397. Coronary Artery Disease (CAD)
  2398. Prognosis
  2399. Non–Drug Treatment
  2400. Drug Treatment
  2401.  Tech Note!
  2402. Thrombosis
  2403. Prognosis
  2404. Non–Drug Treatment
  2405. Drug Treatment
  2406. BOX 23-9
  2407. American Heart Association Guidelines to Prevent Heart Disease
  2408. TABLE 23-5 Examples of Types of Embolisms
  2409. Anticoagulants
  2410. TABLE 23-6 Examples of Anticoagulants
  2411. BOX 23-10
  2412. Heparin Concentrations
  2413. Generic Name: Heparin Sodium
  2414. Trade Name: Heplok
  2415. Low-Molecular-Weight Heparins (LMWHs)
  2416.  Tech Note!
  2417. Anticoagulants
  2418. Antiplatelet Agents
  2419. Thrombolytics
  2420. BOX 23-11
  2421. Enoxaparin (Lovenox)
  2422. Prefilled Injection (PFS)
  2423. Types of Medications Used for Heart Conditions
  2424. Angiotensin-Converting Enzyme Agents (Ace Inhibitors)
  2425.  Tech Note!
  2426. ACE inhibitors (ACEIs)
  2427. TABLE 23-7 Oral Antiplatelet Agents
  2428. TABLE 23-8 Examples of Thrombolytics
  2429. Angiotensin II Receptor Antagonists (Also Known As Angiotensin Receptor Blockers)
  2430. Angiotensin II Receptor Antagonists
  2431. Beta-Blocking Agents
  2432. Beta-Blocking Agents
  2433. Calcium Channel Blockers
  2434. Calcium Channel Blockers
  2435.  Tech Alert!
  2436. Do You Remember These Key Points?
  2437. Review Questions
  2438. Multiple choice questions
  2439. True/False
  2440. Technician’s Corner
  2441. Bibliography
  2442. Websites
  2443. CHAPTER 24 Reproductive System
  2444. Objectives
  2445. Terms and Definitions
  2446. EXAMPLES OF REPRODUCTIVE SYSTEM DRUGS
  2447. TABLE 24-1 Hormone Functions
  2448. MEDICAL TERMINOLOGY OF THE REPRODUCTIVE SYSTEM
  2449. Male Reproductive System
  2450. FIGURE 24-1 Male reproductive system.
  2451. FIGURE 24-2 Function of testes in response to hormone stimulation.
  2452. Conditions Affecting the Male Reproductive System
  2453. TABLE 24-2 Conditions Affecting the Male Reproductive System
  2454. Common Conditions
  2455. Erectile Dysfunction (ED)
  2456. TABLE 24-3 Causes of Erectile Dysfunction
  2457. Prognosis
  2458. Non–Drug Treatments
  2459. Drug Treatments
  2460. Benign Prostatic Hypertrophy (Benign Prostatic Hyperplasia or BPH)
  2461. Prognosis
  2462. Non–Drug Treatment
  2463. TABLE 24-4 Medications for Erectile Dysfunction
  2464. Drug Treatment
  2465. Androgen Hormone Inhibitors
  2466. Alpha-Adrenergic Blockers
  2467. Prostate Cancer
  2468. FIGURE 24-3 Prostate cancer.
  2469. BOX 24-1
  2470. Stages of Prostate Cancer
  2471. TABLE 24-5 Prostate Cancer Treatments
  2472. Prognosis
  2473. Non–Drug Treatment
  2474. Drug Treatment
  2475. Male Hypogonadism
  2476. Prognosis
  2477. Non–Drug Treatment
  2478. Drug Treatment
  2479. Androgens
  2480. Female Reproductive System
  2481. FIGURE 24-4 Female reproductive system.
  2482. Conditions Affecting the Female Reproductive System
  2483. Hormonal Treatments
  2484. FIGURE 24-5 Function of ovaries in response to hormone stimulation.
  2485. Common Conditions
  2486. Female Hypogonadism
  2487. Prognosis
  2488. Non–Drug Treatments
  2489. Drug Treatments
  2490. Pelvic Inflammatory Disease (PID)
  2491. Prognosis
  2492. TABLE 24-6 PID Treatments
  2493. Non–Drug Treatments
  2494. Drug Treatments
  2495. Menopause
  2496. Prognosis
  2497. Non–Drug Treatments
  2498. Drug Treatments
  2499. Estrogen Preparations
  2500. Infertility
  2501. Prognosis
  2502. Non–Drug Treatment
  2503. Drug Treatment
  2504. Ovulation Stimulants
  2505. TABLE 24-7 Infertility Treatments
  2506. Luteinizing Hormone and Follicle-Stimulating Hormone Stimulants
  2507. Ergot Alkaloid
  2508. Progestins
  2509. Menstrual Disorders
  2510. Prophylaxis Medications
  2511. Oral Contraceptives (OCs)
  2512. FIGURE 24-6 Common contraceptives, including barrier and medicinal methods: condoms, diaphragm, oral contraceptives, and parenteral contraceptives.
  2513. BOX 24-2
  2514. Menstrual Disorders
  2515.  Tech Note!
  2516. Long-Acting Contraceptive
  2517. Intrauterine Progesterone Contraception
  2518.  Tech Note!
  2519. Other Contraceptives
  2520.  Tech Note!
  2521. TABLE 24-8 Contraceptive Methods: Risks, Complications, and Failure
  2522. Sexually Transmitted Diseases (STDs)
  2523.  Tech Alert!
  2524. Do You Remember These Key Points?
  2525. TABLE 24-9 Sexually Transmitted Disease Organisms and Various Drug Therapies
  2526. Review Questions
  2527. Multiple choice questions
  2528. True/False
  2529. Technician’s Corner
  2530. Bibliography
  2531. Websites
  2532. Section Three Classification of Drugs
  2533. CHAPTER 25 Antiinfectives
  2534. Objectives
  2535. Terms and Definitions
  2536. EXAMPLES OF ANTIINFECTIVES
  2537. TERMINOLOGY RELATED TO ANTIINFECTIVES
  2538. History of Antibiotics
  2539. The Discovery of Penicillin
  2540. Gram Stain
  2541. Modern Antibiotics
  2542. FIGURE 25-1 A Petri dish is prepared with nutrient-rich agar. This nutrient feeds the bacteria that are placed on the plate. The Penicillium colony can be seen with an area of clearance where the bacteria cannot grow. This occurs because the Penicillium colony inhibits the bacterial growth.
  2543. Types of Infections and Their Treatments
  2544. Sexually Transmitted Diseases
  2545. Gastrointestinal Infections
  2546. FIGURE 25-2 Helicobacter pylori, a bacterium that causes infection of the stomach.
  2547. TABLE 25-1 Types of Microorganisms and Parasites
  2548. TABLE 25-2 Common Sexually Transmitted Diseases and Treatments
  2549. Respiratory Infections
  2550. Nosocomial Infections
  2551. Multidrug-Resistant Organisms (MDROs)
  2552. BOX 25-1
  2553. MDROs
  2554. TABLE 25-3 Potentially Fatal “Superbugs”
  2555. Methicillin-Resistant Staphylococcus aureus (MRSA)
  2556. Vancomycin-Resistant Staphylococcus aureus (VRSA)
  2557. Multidrug-Resistant S. pneumoniae (MDRSP)
  2558. Gram-Negative Resistant Bacilli (GNRB)
  2559. Vancomycin-Resistant Enterococcus (VRE)
  2560. The Centers For Disease Control And Prevention (CDC)
  2561. Infections of the Skin
  2562. Infections of the Nose and Mouth
  2563. BOX 25-2
  2564. Nationally Notifiable Infectious Diseases 2010
  2565. Centers for Disease Control
  2566. Infections of the Eyes and Ears
  2567. Antibiotic Treatments
  2568.  Tech Note!
  2569. Penicillin
  2570. FIGURE 25-3 Tinea pedis, a fungal infection that causes athlete’s foot.
  2571. TABLE 25-4 Otic and Ophthalmic Antiinfectives, Examples
  2572. Antibacterial, Penicillins
  2573. TABLE 25-5 Examples of Bacterial Morphology, Areas Affected, Treatment, and Conditions
  2574.  Tech Note!
  2575. Cephalosporins
  2576. Mycobacterium and Mycobacterial Treatment
  2577. TABLE 25-6 Antibiotics Other Than Penicillins and Cephalosporins
  2578.  Tech Note!
  2579. Aminoglycosides
  2580. TABLE 25-7 Antituberculin Agents
  2581. Drug-Resistant and Miscellaneous Antibiotics
  2582. TABLE 25-8 Antibiotics for Resistant Microorganisms
  2583. Antifungals
  2584. Candida Infections
  2585. TABLE 25-9 Fungal Infections and Their Treatments
  2586. FIGURE 25-4 Types of tinea infections. A, Tinea cruris. B, Tinea capitis. C, Tinea corporis.
  2587. BOX 25-3
  2588. Parasitic Organisms and Their Description
  2589. Tinea Infections
  2590. Parasites
  2591. TABLE 25-10 Protozoan Infections and Their Treatments
  2592. Protozoa
  2593. Helminths (Worms)
  2594. TABLE 25-11 Helminthic Infestations and Their Treatments
  2595. Parasitic Treatments
  2596. Malaria
  2597. TABLE 25-12 Anthelmintic Drug Actions and Common Dosage
  2598. Antivirals
  2599. BOX 25-4
  2600. Antiviral Mechanisms of Action
  2601. TABLE 25-13 Antiviral and Antiretroviral Agents
  2602. HIV/AIDS
  2603.  Tech Note!
  2604. Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
  2605. Non-Nucleoside Reverse Transcriptase Inhibitors
  2606. Protease Inhibitors (PIs)
  2607.  Tech Note!
  2608. Colds/Flu
  2609. Miscellaneous Viral Conditions
  2610. Human Papillomavirus (HPV)
  2611. Herpes Viruses
  2612. BOX 25-5
  2613. Types of Human Herpes Viruses
  2614. Herpes Simplex
  2615. Herpes Zoster (Shingles)
  2616. Varicella Zoster Chickenpox
  2617.  Tech Alert!
  2618. Do You Remember These Key Points?
  2619. Review Questions
  2620. Multiple choice questions
  2621. True/False
  2622. Technician’s Corner
  2623. Use
  2624. Agents
  2625. Bibliography
  2626. Websites
  2627. CHAPTER 26 Antiinflammatories and Antihistamines
  2628. Objectives
  2629. Terms and Definitions
  2630. COMMON ANTIINFLAMMATORY AGENTS
  2631. The Inflammatory Response
  2632. TABLE 26-1 Immune Cell Responses in Injury
  2633. TABLE 26-2 Types of Inflammatory Conditions
  2634. ANTIINFLAMMATORY AND ANTIHISTAMINE TERMINOLOGY
  2635. The Body’s Natural Response
  2636. Glucocorticoids (Steroids)
  2637. Adrenal Effects of Steroid Agents
  2638. FIGURE 26-1 Prednisone-tapered prescription.
  2639. Corticosteroids
  2640. BOX 26-1
  2641. Corticosteroid Dosage Forms and Uses
  2642. TABLE 26-3 Examples of Corticosteroidal Agents and Dosage Forms
  2643. Corticosteroids
  2644. Inflammatory Pain
  2645. FIGURE 26-2 Pain route.
  2646.  Tech Note!
  2647. Pain and Inflammation Medications
  2648. Aspirin
  2649. TABLE 26-4 Various Strengths of Aspirin Available
  2650.  Tech Note!
  2651. Nonsteroidal Antiinflammatory Drugs (NSAIDs)
  2652. TABLE 26-5 Nonsteroidal Antiinflammatory Drugs, Cyclooxygenase-2 Inhibitors, and Similar Agents*
  2653. Cyclooxygenase-2 Inhibitors
  2654. Cox-2 Inhibitors
  2655. Controlled Analgesics
  2656. Inflammatory Conditions
  2657. Common Conditions
  2658. Osteoarthritis
  2659. Prognosis
  2660. Non–Drug Treatment
  2661. FIGURE 26-3 Severe osteoarthritis.
  2662. Drug Treatment
  2663. Rheumatoid Arthritis (RA)
  2664. FIGURE 26-4 Severe rheumatoid arthritis.
  2665. Prognosis
  2666. Non–Drug Treatment
  2667. Drug Treatment
  2668. Biological Response Modifiers
  2669. Disease-Modifying Antirheumatic Drugs
  2670. Allergies
  2671. FIGURE 26-5 Asthma: airways become obstructed by mucus and edema, causing dyspnea.
  2672. Allergic Conditions and Their Treatments
  2673. FIGURE 26-6 Events that take place in an allergic reaction, from the first exposure to an antigen to the allergic response.
  2674. BOX 26-2
  2675. Types of Antigens
  2676. BOX 26-3
  2677. Allergic Conditions
  2678. Allergic Rhinitis
  2679. Symptoms of Allergic Rhinitis
  2680. Contact Dermatitis
  2681. Symptoms of Contact Dermatitis
  2682. Atopic Dermatitis
  2683. Symptoms of Atopic Dermatitis
  2684. Drug Allergies
  2685. Symptoms of Drug Allergies
  2686. Food Allergies
  2687. Symptoms of Food Allergies
  2688. Antihistamines and Combination Drugs
  2689. TABLE 26-6 Ophthalmics for Allergic Inflammation (Mast Cell Stabilizers)
  2690. TABLE 26-7 Examples of Oral Antihistamines
  2691. TABLE 26-8 Oral Combination Antihistamine/Decongestant OTC Agents
  2692. Drug Interactions
  2693. Antihistamines
  2694. TABLE 26-9 Nasal OTC Decongestant Agents
  2695. TABLE 26-10 Intranasal Prescription Steroids
  2696. TABLE 26-11 Ophthalmic Steroidal Prescription Agents
  2697. TABLE 26-12 Topical Steroidal Treatment
  2698. Commonly Used Antihistamines
  2699. Common Nasal Corticosteroids
  2700.  Tech Alert!
  2701. Anaphylaxis
  2702.  Tech Alert!
  2703. Do You Remember These Key Points?
  2704. Review Questions
  2705. Multiple choice questions
  2706. True/False
  2707. Technician’s Corner
  2708. Bibliography
  2709. Websites
  2710. CHAPTER 27 Vitamins and Minerals
  2711. Objectives
  2712. Terms and Definitions
  2713. VITAMINS
  2714. MINERALS
  2715. History of Regulation of Vitamin and Mineral Supplements
  2716. BOX 27-1
  2717. Food and Drug Administration Regulatory Requirements for Dietary Supplements and Nonregulated Items
  2718. Regulatory Requirements:
  2719. The Manufacturers Must Also State on All Containers:
  2720. Vitamins
  2721.  Tech Alert!
  2722. Fat-Soluble Vitamins (A, D, E, and K)
  2723. TABLE 27-1 Drug Interactions of Fat-Soluble Vitamins
  2724. TABLE 27-2 DRI Values for Fat-Soluble Vitamins
  2725. Vitamin A
  2726. Sources of Vitamin A
  2727. Hypervitaminosis A
  2728. Vitamin D
  2729. Sources of Vitamin D
  2730. Deficiency of Vitamin D
  2731. FIGURE 27-1 Rickets.
  2732. Hypervitaminosis D
  2733. Drug Interactions
  2734. Vitamin E
  2735. Sources of Vitamin E
  2736. Deficiency of Vitamin E
  2737. Hypervitaminosis E
  2738. Drug Interactions
  2739. Vitamin K (Phytonadione)
  2740. Sources of Vitamin K
  2741. Deficiency of Vitamin K
  2742. Water-Soluble Vitamins (B and C)
  2743. TABLE 27-3 DRI Values for Water-Soluble Vitamins
  2744. B Vitamins
  2745. Sources of B Vitamins
  2746. TABLE 27-4 Water-Soluble Vitamins: Overdose and Drug Interactions
  2747. TABLE 27-5 B Vitamins: Sources, Function, and Deficiency States
  2748. Deficiencies of B Vitamins
  2749. Vitamin B1 (Coenzyme)
  2750. Deficiency of Vitamin B1
  2751. Drug Interactions with Vitamin B1
  2752. Vitamin B2 (Coenzyme)
  2753. Deficiency of Vitamin B2
  2754.  Tech Note!
  2755. Vitamin B3 (Coenzyme)
  2756. Deficiency of Vitamin B3
  2757.  Tech Note!
  2758. Vitamin B5 (Coenzyme)
  2759. Deficiency of Vitamin B5
  2760. Vitamin B6 (Coenzyme)
  2761. Deficiency of Vitamin B6
  2762. Drug Interactions with Vitamin B6
  2763. Vitamin B7 (Biotin)
  2764. Deficiency of Vitamin B7
  2765. Vitamin B9 (Coenzyme)
  2766. Deficiency of Vitamin B9
  2767. Interactions with Vitamin B9
  2768. Vitamin B12 (Coenzyme)
  2769. Deficiency of Vitamin B12
  2770.  Tech Note!
  2771. Vitamin C
  2772. Deficiency of Vitamin C
  2773. Antioxidants
  2774. Minerals
  2775. Zinc
  2776. TABLE 27-6 Common Minerals and Trace Elements, Their Actions, and Deficiencies
  2777. Drug Interactions
  2778. iron
  2779. TABLE 27-7 DRI Values for Minerals and Trace Elements
  2780. TABLE 27-8 Mineral Sources
  2781. TABLE 27-9 Iron Sources
  2782. TABLE 27-10 DRI for Elemental Iron
  2783. Iron Deficiency
  2784. Do You Remember These Key Points?
  2785. Review Questions
  2786. Multiple choice questions
  2787. True/False
  2788. Technician’s Corner
  2789. Bibliography
  2790. Websites
  2791. CHAPTER 28 Vaccines
  2792. Objectives
  2793. Terms and Definitions
  2794. TYPES OF VACCINES
  2795. SYSTEMIC IMMUNOSUPPRESSIVE AGENTS (EXCLUDES CORTICOSTEROIDS)
  2796. Lymphatic System
  2797. Thymus
  2798. Tonsils
  2799. Spleen
  2800. Types of Immune Cells
  2801. FIGURE 28-1 Overview of the major lymphatic organs within the body.
  2802. Immunizations
  2803. TABLE 28-1 Major Immune Response Cells
  2804. BOX 28-1
  2805. Brief Overview of All Immune Cells
  2806. Types of Immunity
  2807. Active Immunity
  2808. Passive Immunity
  2809.  Tech Note!
  2810. How Vaccines are Prepared
  2811. Viral Vaccines
  2812. Bacterial Vaccines
  2813. Miscellaneous Vaccines
  2814. TABLE 28-2 Common Viral Vaccines, Diseases Treated, and Route of Administration
  2815. TABLE 28-3 Common Toxoids and Route of Administration
  2816. Development of Vaccines
  2817. BOX 28-2
  2818. Three Types of Less Common Vaccines and Their Specific Characteristics
  2819. Antiidiotypic Vaccines
  2820. Subunit Vaccines
  2821. Acellular and Conjugated Vaccines
  2822. TABLE 28-4 Vaccines That Prevent Diseases
  2823. TABLE 28-5 Childhood Immunization Schedule
  2824. Childhood Immunization
  2825. National Childhood Vaccine Injury Act of 1986
  2826.  Tech Note!
  2827. Autism and Vaccines
  2828. Diphtheria, Pertussis, and Tetanus Infections and Vaccines
  2829. Vaccines for Diphtheria, Pertussis, and Tetanus Infections
  2830. Polio
  2831. Vaccine for Polio
  2832. Measles, Mumps, and Rubella
  2833. FIGURE 28-2 A, Measles. Symptoms include rash, consisting of both papules and macules, that spreads over the body and lasts 3 to 5 days. B, Mumps. Glands become swollen, causing pain when chewing or drinking liquids. Symptoms last approximately 24 hours. C, Rubella. Lymph nodes enlarge, and a fine red rash occurs. Symptoms last approximately 2 to 3 days.
  2834. Vaccine for Measles, Mumps, and Rubella
  2835. Chickenpox
  2836. Vaccine for Chickenpox
  2837. FIGURE 28-3 Chickenpox. Rash begins with macules, which turn into severe papules. Symptoms can last from a few days to 2 weeks.
  2838. Herpes Zoster
  2839. Hepatitis Infections and Vaccines
  2840. Hepatitis A Virus (HAV)
  2841. Vaccine
  2842. Hepatitis B Virus (HBV)
  2843. BOX 28-3
  2844. Hepatitis Infections with No Available Vaccines
  2845. Vaccine
  2846. Active Treatment
  2847. Hepatitis C Virus (HCV)
  2848. Vaccine
  2849. Active Treatment
  2850. Hepatitis D Virus (HDV)
  2851. Vaccine
  2852. Other Viruses and Vaccines
  2853. Human Papillomavirus
  2854. Vaccine
  2855. Pneumonia
  2856. Vaccine
  2857. Haemophilus influenzae Type B
  2858. Vaccine
  2859. Influenza
  2860. Vaccines
  2861. Swine Flu (H1N1)
  2862. Vaccine
  2863. Passive ImmunitY
  2864. Travel Medicine and Immunizations
  2865. Antitoxins and Antivenins
  2866.  Tech Note!
  2867. Storage of Vaccines
  2868. TABLE 28-6 Types of Vaccines
  2869.  Tech Note!
  2870. Immune Therapies
  2871. Special Situations for Vaccination—Pregnancy
  2872. TABLE 28-7 Examples of Biological/Immune Therapies
  2873.  Tech Alert!
  2874. Do You Remember These Key Points?
  2875. Review Questions
  2876. Multiple choice questions
  2877. True/False
  2878. Technician’s Corner
  2879. Bibliography
  2880. Websites
  2881. CHAPTER 29 Oncology Agents
  2882. Objectives
  2883. Terms and Definitions
  2884. CHEMOTHERAPEUTIC AGENTS
  2885. CONTROLLED OPIOID ANALGESICS COMMONLY USED FOR CANCER PAIN
  2886. What Is Cancer?
  2887. MEDICAL TERMINOLOGY
  2888. FIGURE 29-1 Metastasis of cancer. Diagram shows how lung cancer may metastasize to other areas of the body.
  2889. What Causes Cancer?
  2890. Types of Cancer
  2891. TABLE 29-1 Types of Cancer
  2892. BOX 29-1
  2893. Types of Cancer and Where They occur
  2894. FIGURE 29-2 Lymph node sites where Hodgkin’s disease can strike.
  2895. FIGURE 29-3 Kaposi’s sarcoma.
  2896. FIGURE 29-4 Malignant mesothelioma.
  2897. BOX 29-2
  2898. Characteristics of Cancer Growth and Treatment
  2899. Diagnosis of Cancer
  2900. Treatments for Cancer
  2901. Surgery
  2902. TABLE 29-2 Combination Therapies for Cancer
  2903.  Tech Note!
  2904. Radiation
  2905. Side Effects of Radiation Therapy
  2906. FIGURE 29-5 Radiation dermatitis from exposure to radiation treatment for cancer.
  2907. BOX 29-3
  2908. Forms of Treatment
  2909. Radioactive Isotopes
  2910. Chemotherapy
  2911. TABLE 29-3 Common Types of Chemotherapeutic Agents
  2912. TABLE 29-4 Routes of Administration of Chemotherapeutic Agents
  2913. Targeted Therapy
  2914. Agents Used in the Treatment of Neoplastic Diseases
  2915. Antimetabolite Agents
  2916. Antibiotics
  2917. Mitotic Inhibitors
  2918. FIGURE 29-6 Mitosis.
  2919. Alkylating Agents
  2920. Nitrogen Mustards
  2921. Nitrosoureas
  2922. Other Antineoplastic Agents
  2923.  Tech Note!
  2924. Side Effects of Chemotherapy and BiologicAL Treatments
  2925. TABLE 29-5 Other Cancer Treatment Agents
  2926. Adjunctive Agents
  2927. Erythropoietin
  2928. Filgrastim
  2929. TABLE 29-6 Treatment of Chemotherapy Side Effects
  2930. Cytoprotective Agents
  2931. Other Types of Treatment
  2932. Chemoradiotherapy (CRT)
  2933. Radiopharmaceuticals
  2934. BOX 29-4
  2935. Examples of Radiopharmaceuticals and Their Use
  2936. Biological Therapy
  2937.  Tech Note!
  2938. Hyperthermia
  2939. Photodynamic Therapy
  2940. Complementary and Alternative Medicine
  2941. Pain ControL
  2942. Cancer Survival Rates
  2943.  Tech Alert!
  2944. TABLE 29-7 Estimated Deaths Attributable to Cancer for 2009
  2945. Do You Remember These Key Points?
  2946. Review Questions
  2947. Multiple choice questions
  2948. True/False
  2949. Technician’s Corner
  2950. Bibliography
  2951. Websites
  2952. Section Four Basic Sciences for the Pharmacy Technician
  2953. CHAPTER 30 Microbiology
  2954. Objectives
  2955. Terms and Definitions
  2956. EXAMPLES OF ORGANISMS AND DISEASES THEY CAUSE
  2957. Charles Darwin (Evolution)
  2958. The Golden Age of Microbiology
  2959. Louis Pasteur
  2960. FIGURE 30-1 The golden age of microbiology.
  2961. Classifications of Organisms (Taxonomy)
  2962. TABLE 30-1 Kingdoms, Cell Characteristics, and Examples
  2963. Robert Whittaker (The Five Kingdoms)
  2964. Plantae
  2965. Plant Cell Structure
  2966. FIGURE 30-2 Major components of a plant cell.
  2967. Animalia
  2968. FIGURE 30-3 Cell composition of an animal cell.
  2969. Animal: Eukaryotic Cell Structure
  2970. TABLE 30-2 Characteristics and Structure of an Animal (Eukaryotic) Cell
  2971. Protista
  2972. FIGURE 30-4 Three forms of locomotion in protozoa.
  2973. How Parasites Are Transmitted
  2974. FIGURE 30-5 Life cycle of Plasmodium vivax.
  2975. TABLE 30-3 Parasitic Diseases Contracted by Human Beings
  2976. Fungi
  2977.  Tech Note!
  2978. FIGURE 30-6 The budding process of replication of yeast cells. Yeast multiplies asexually by budding or sprouting a new cell that then breaks away from the mother cell.
  2979. FIGURE 30-7 Morphology of prokaryotic organisms. Pictures 1 to 6 show the various morphologies or shapes of microbes. The most common shapes include the following: 1, coccus; 2, bacilli; 3, spirilla; 4, vibrios. Picture 5 shows cocci microbes that are found in sets of two, called diplococci or diplobacilli. Those microbes found in strips are shown in picture 6: streptococci or streptobacilli. Picture 7 shows staphylococci and staphylobacilli, which are found in clusters.
  2980. Monera
  2981. Characteristics and Structure of Prokaryotes
  2982. Brief History of Antibiotics
  2983. Structure of the Bacterial Cell Wall
  2984. Exterior of Bacterial Cell Walls
  2985. Antibiotic Spectrum and Resistance
  2986. FIGURE 30-8 Bacterial cell walls.
  2987.  Tech Note!
  2988. Human Diseases and Conditions
  2989. Diseases Caused by Organisms within the Plantae Kingdom
  2990. TABLE 30-4 Classes of Microorganisms within the Kingdom Monera
  2991. TABLE 30-5 Commonly Caused Bacterial Conditions
  2992. BOX 30-1
  2993. Examples of Common Plants that Can Cause Harm to Humans and Animals
  2994.  Tech Alert!
  2995. Diseases Caused by Organisms within the AnimalIA Kingdom
  2996. FIGURE 30-9 Poison oak infection.
  2997. Diseases Caused by Organisms within the ProTISTA Kingdom
  2998. FIGURE 30-10 Brown recluse spider bite.
  2999. Diseases Caused by Organisms within the Monera Kingdom
  3000. FIGURE 30-11 Rocky Mountain spotted fever.
  3001. Diseases Caused by Fungus
  3002. BOX 30-2
  3003. Conditions Caused by Fungi
  3004. Viruses
  3005. Classification of Viruses
  3006. Morphology and Characteristics of Viruses
  3007. FIGURE 30-12 Viral composition. A, Unenveloped (capsomeres). B, Enveloped virus. C, Bacteriophage.
  3008. FIGURE 30-13 Human immunodeficiency virus replication. Diagram of the replication process of viruses. Each component is made independently inside the host cell. All materials are made from the host cell. Once the parts are made, they are assembled.
  3009. Analysis of Virions
  3010. FIGURE 30-14 Determination of antibody formation: antibody test using bacteriophages. This proves whether a person has formed antibodies against a certain antigen. A, A sample of blood (containing an antibody, O) is placed in a beaker. Two components are added to this beaker: a complement (color when bound to antigen and antibody) and the antigen (A) to the antibody. B, The result would be that O and A bind, resulting in a color that makes this test positive. C, A sample of blood (with no antibody) is placed in a beaker. The two components are then added to the beaker. The result in this case is negative because there is no antibody present to complete the color change. Thus the blood has no previous contact with that specific antigen.
  3011. Diseases Caused by Viruses
  3012. TABLE 30-6 Well-Known Viral Diseases
  3013. How Viral Infections are Stopped
  3014. Using Viruses to Fight Disease
  3015. FIGURE 30-15 The four ways to stop viral infections.
  3016. BOX 30-3
  3017. Methods of Viral Inhibition
  3018. Do You Remember These Key Points?
  3019. Review Questions
  3020. Multiple choice questions
  3021. True/False
  3022. Technician’s Corner
  3023. Bibliography
  3024. Websites
  3025. CHAPTER 31 Chemistry
  3026. Objectives
  3027. Terms and Definitions
  3028. Parts of an Atom
  3029.  Tech Note!
  3030. FIGURE 31-1 Electron orbit.
  3031. FIGURE 31-2 Periodic table of elements. The elements K, Na, Cl, Mg, Se, and Cu are highlighted.
  3032.  Tech Note!
  3033. Molecules
  3034. Enzyme Activators and Inhibitors
  3035. FIGURE 31-3 Carbon, represented by the letter C. Below the element is the atomic number. Above is the atomic weight.
  3036. FIGURE 31-4 Water molecule formation. Water is one of the most important compounds on earth. Water composes approximately 65% to 75% of all living cells.
  3037. TABLE 31-1 Chemical Charges of Compounds
  3038.  Tech Note!
  3039. Metabolism: Anabolism and Catabolism
  3040. Electrolyte and Mineral Replacement
  3041. Hyperalimentation Example: Electrolytes in Clinical Practice
  3042. Chemistry in Clinical Practice: Drug and Food Chemical Reactions
  3043. Acid-Base Reactions
  3044. TABLE 31-2 Interactions between Ions and Medications
  3045.  Tech Note!
  3046. Amino Acids
  3047. FIGURE 31-5 Amino acid structure.
  3048. FIGURE 31-6 Essential amino acids for human life. They are the basis for proteins that are responsible for normal body functions.
  3049.  Tech Note!
  3050. Conclusion
  3051. Do You Remember These Key Points?
  3052. Review Questions
  3053. Multiple choice questions
  3054. True/False
  3055. Technician’s Corner
  3056. Bibliography
  3057. Back Matter
  3058. Appendix A Review for the PTCB Examination
  3059. Answer Key
  3060. Appendix B 200 Top Selling Trade Name Drugs for 2009
  3061. APPENDIX C Top 30 Herbal Remedies
  3062. Glossary
  3063. Abbreviations
  3064. Common Disease States/Conditions
  3065. Drug and Solution Abbreviations
  3066. Measurements
  3067. Drug Dose Intervals, Forms, and Instructions
  3068. Organizations
  3069. Pharmacy Chemical Abbreviations and Terms
  3070. Medical Terms/Abbreviations
  3071. Medical Personnel Titles
  3072. Miscellaneous
  3073. Reference Book Abbreviations
  3074. Math Review for Pharmacy Technicians
  3075. Proportions
  3076. Method 1: Cross Multiply and Divide
  3077. Method 2: Means and Extremes
  3078. Questions
  3079. Percents
  3080. Rules
  3081. Questions
  3082. Metric, Household, and Apothecary Conversions
  3083. Metric System
  3084. Weight (gram)
  3085. Volume (liter)
  3086. Household System
  3087. Weight
  3088. Volume
  3089. Apothecary System
  3090. Weight
  3091. Volume
  3092. Questions
  3093. Units
  3094. Questions
  3095. Milliequivalents
  3096. Questions
  3097. Pediatric Dosages
  3098. Example 1
  3099. Example 2
  3100. Questions
  3101. Concentration/Dilution
  3102. Three Hints to Prevent Errors in Solving Dilution Problems
  3103. Questions
  3104. Alligation
  3105. Questions
  3106. Drip Flow Rates
  3107. Questions
  3108. Temperature Conversions
  3109. Questions
  3110. Health Insurance Portability and Accountability Act of 1996 (HIPAA)
  3111. What Information Is Protected?
  3112. Permitted Uses and Disclosures
  3113. Workforce Training and Management
  3114. Data Safeguards
  3115. Documentation and Record Retention
  3116. Civil Money Penalties
  3117. Criminal Penalties
  3118. What Does This Mean to You and Other Pharmacy Personnel?
  3119. Scenarios
  3120. Student Case Scenarios
  3121. 200 Top Selling Trade Name Drugs for 2009